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Riassunto
Il Calcio (Ca2+) e’ uno dei principali messaggeri intracellulari coinvolto quasi in tutti gli 
aspetti della vita cellulare. In particolare, il Ca2+ gioca un ruolo essenziale nello sviluppo 
neuronale, plasticità e trasmissione sinaptica, come anche nella regolazione delle vie 
metaboliche e dell’apoptosi.
Il primo obbiettivo del mio lavoro è stato studiare in dettaglio l’apparato di golgi (AG) 
come riserva intracellulare di Ca2+.
Il complesso del Golgi può contenere più del 5% della totalità del Ca2+ cellulare a 
concentrazioni significativamente maggiori che in altre regioni cellulari. L’apparato del 
Golgi contiene tipicamente anche una moltitudine di proteine leganti Ca2+ e canali per il 
Ca2+. L’uso di una sonda cameleon specificamente indirizzata al trans-Golgi, ci ha 
permesso di dimostrare direttamente l'eterogeneità funzionale dell’AG mettendo in luce le 
caratteristiche distinte di questo subcompartimento: l’accumulo di Ca2+ avviene 
esclusivamente tramite SPCA1 (e non tramite SERCA); inoltre, in risposta a generazione 
di IP3 non c’è rilascio di Ca2+, ma un suo piccolo accumulo come conseguenza 
dell’aumento di Ca2+ citosolico.  
Usando una nuova sonda per il Ca2+ basata sulle GFP selettivamente indirizzata nel cis/
medial-Golgi, (mGo-D1cpv), abbiamo dimostrato che il medial-Golgi si comporta in una 
maniera unica, rilasciandolo Ca2+ dopo stimolazione non solo di agonisti liberanti IP3, ma 
anche attraverso il recettore rianodinico (RyR) e basandosi, per l’accumulo di Ca2+, sia 
sulla SERCA che su SPCA1.
In conclusione, l’AG rappresenta uno store intracellulare di Ca2+ con un alto grado di 
complessità. In uno spazio di pochi micron e nonostante il suo continuo intermescolamento 
dei vari subcompartimenti, il set di proteine che regolano l’omeostasi Ca2+ cambia in 
maniera consistente, separando sub-regioni funzionali, con differenti proteine regolanti il 
Ca2+, contriburndo alla sua omeostasi.
Il secondo obbiettivo del mio lavoro è stato studiare in dettaglio, utilizzando sonde 
cameleon  specificamente indirizzate, l’effetto di mutazioni familiari del morbo di 
Alzheimer (FAD) nei geni delle preseniline (PSs) 1 e 2.
Nel nostro laboratorio è stato recentemente visto che la mutazione FAD PS2 riduce il 
contenuto di Ca2+ del principale store cellulare: il reticolo endoplasmatico (RE), 
principalmente inibendo l'attività della SERCA, come dimostrato a livello di popolazione 
cellulare utilizzando la sonda Ca2+ equorina indirizzata al RE.
Per studiare l’effetto dell’espressione delle mutazioni FAD sull’omeostasi del Ca2+ nel RE 
in esperimenti FRET su singola cellula, abbiamo creato la nuova sonda cameleon 
indirizzata al RE (ERD4) con  ottimizzate affinità al Ca2+ e range dinamico.
L’omeostasi del Ca2+ nei diversi subcompartimenti, a livello di singola cellula, sono stati 
studiati nella linea cellulare SH-SY5Y sovra-esprimendo  PS2 wild type (wt), PS2-T122R, 
PS1 wt opppure PS1-A246E, e anche in fibroblasti umani da pazienti FAD-PS2-N141I e 
FAD-PS1-A246E (con i rispettivi fibroblasti di controllo da controlli sani della stessa età e 
sesso).
La concentrazione di Ca2+ ([Ca2+]) di RE e medial-Golgi, in cellule a riposo, è fortemente 
ridotta dalle PS2 mutate o wt (quest’ultima solo in sovra-espressione), ma non dalla PS1 
mutata. Nel trans-Golgi, invece, la [Ca2+] in cellule a riposo risulta non essere alterata in 
nessun caso.
Inoltre, il tasso di accumulo di Ca2+ in questi stores viene ridotto dalle PS2 mutate o wt 
(quest’ultima solo in sovra-espressione) e, solo nel medial-Golgi, il tasso di fuoriuscita del 
Ca2+ è potenziata. Questi risultati rafforzano la nostra ipotesi di un effetto inibitorio da 
parte della PS2 mutata  sull'attività della SERCA. Tali risultati sono anche consistenti con 
il fatto che, all’interno del Golgi, solo il compartimento cis/medial ha  il recettore IP3 e la 
pompa SERCA, mentre il trans-Golgi è mancante di entrambi.
In conclusione, i nostri dati fanno luce sull'eterogeneità molecolare di diversi store 
intracellulari per il Ca2+ (e in distinti subcompartimenti dello stesso organello) e 
aggiungono nuovi dettagli per comprendere i meccanismi attraverso cui le PSs influenzano 
l’omeostasi del Ca2+ e la patogenesi delle FAD.
In prospettiva futura, queste sonde cameleon saranno utilizzate per studiare alterazioni 
sull’omeostasi del Ca2+ indotte da mutazioni FAD-PS2 e, eventualmente, in vivo 
utilizzando vettori virali. 
Summary
Calcium (Ca2+) is one of the major intracellular messengers that impacts nearly 
every aspect of cell life. In particular, it plays essential roles in neuronal 
development, synaptic transmission and plasticity, as well as in the regulation of 
metabolic pathways and cell fate decisions. 
The first  goal of my work was to study more in details the Golgi apparatus (GA), 
as an intracellular Ca2+ store.
The Golgi complex may store up to 5% of the total cellular Ca2+ at higher 
concentrations and contains several different luminal Ca2+-binding proteins and 
Ca2+-release channels. The use of a specific Cameleon Ca2+ sensor targeted to the 
trans-Golgi, allowed us to directly  demonstrate the functional GA heterogeneity 
by  showing the distinct behaviour of this sub-compartment: it takes up  Ca2+ 
almost exclusively via SPCA1 (and not by SERCA); it  does not release Ca2+ in 
response to IP3 generation, but rather accumulates the cation as a consequence of 
the cytoplasmic Ca2+ rise.
Using a novel GFP-based Ca2+ probe selectively localized to the medial-Golgi 
(mGo-D1cpV), we have demonstrated that  this sub-compartment behaves in a 
unique way, releasing Ca2+ upon cell stimulation not only with IP3-generating 
agonists, but also through Ryanodin receptors (RyRs) and relying, for its Ca2+ 
uptake, on both SERCA and SPCA1 pumps.
The GA represents, thus, an intracellular Ca2+ store with an high complexity 
level. In a space of a few microns and despite its continuous inter-mixing 
dynamics, the Ca2+ toolkit undergoes major changes and distinct, separate 
functional sub-regions, with different Ca2+ features, contribute to its Ca2+ 
handling.
The second aim of my work was to study, at the single cell level by  employing 
specifically targeted cameleon Ca2+ probes, the effect of Familial Alzheimer’s 
Disease (FAD) presenilin 1 and 2 (PS1, PS2) mutants on Ca2+ homeostasis in 
different sub-cellular compartments: the endoplasmic reticulum (ER), the medial 
and trans-Golgi.
Ca2+ dyshomeostasis has been demonstrated in AD, in particular in the rare 
genetically inherited FAD cases (mostly due to mutations in PS1 and PS2 genes).
In our lab has been recently shown, by employing an ER-targeted aequorin Ca2+ 
sensor at the cell population level, that FAD-PS2 mutants reduce the Ca2+ content 
of the major intracellular Ca2+ store, the ER, mostly by inhibiting SERCA 
activity.
In order to deeper investigate the effect of the expression of FAD-PS mutants on 
ER Ca2+ handling in single cell FRET-experiments, we created a novel ER-
targeted cameleon Ca2+ probe (ER-D4) with optimized Ca2+ affinity and dynamic 
range. In addition, the new cameleon Ca2+ probe targeted to the medial-Golgi, 
above described, was also used for a similar purpose.
Ca2+ handling by the distinct intracellular compartments, at single cell level, was 
evaluated in SHSY5Y cell line over-expressing PS2 wild type (wt), FAD-PS2-
T122R, PS1 wt or  FAD-PS1-A246E and also in human fibroblasts from a FAD-
PS2-N141I and a FAD-PS1-A246E patient (and corresponding controls from 
individuals of the same age and sex).
Ca2+ concentration ([Ca2+]) of the ER and the medial-Golgi, in resting cells, is 
strongly  reduced by  PS2, but not PS1, mutants expression, while that  of the 
trans-Golgi compartment results unaffected by both mutants.
The Ca2+ uptake rate in these stores is reduced by PS2 mutants expression and, 
only within the medial-Golgi, also the Ca2+ leak rate is potentiated. 
These findings strength our previous data showing the inhibitory  effect of FAD-
PS2 on SERCA activity. They  are also consistent with the fact that, within the 
Golgi, only the medial-compartment is endowed with IP3 receptors and SERCA 
pumps, whereas the trans-Golgi is devoid of both.
In conclusion, the data highlight the molecular heterogeneity of different 
intracellular Ca2+ stores (and in distinct sub-compartments of the same organelle) 
and provide new insights for the comprehension of the mechanisms through 
which PSs influences cellular Ca2+ homeostasis and FAD pathogenesis.
In the future, these cameleon probes will be applied to study Ca2+ alterations 
induced by FAD-PS2 mutations and, eventually, in vivo by means of viral 
vectors.
Introduction
1. Ca2+ signalling
In milion  years of adaptation to different environments cells have developed 
different and complex signal systems that changes both in time and space 
(Clapham D.E., 2007). Calcium (Ca2+) is one of the most important second 
messengers able to regulate many different cellular functions (Berridge M.J. et 
al., 2003).
Normally, in resting condition, cells maintain a huge Ca2+ gradient between their 
cytoplasm, that has a Ca2+ concentration ([Ca2+]) of ~100 nM, and the 
extracellular medium (1.5-2 mM) and some intracellular organelles, that can 
reach concentrations of several hundreds micromolar. In order to maintain this 
gradient, cells extrude Ca2+ from the cytoplasm through different  energy-
dependent mechanisms (Fig. 1). Cytosolic [Ca2+] is strictly  controlled by 
different systems which extrude it  through the plasma membrane (exchangers 
and pumps), bind it (buffers) or compartimentalize it within different  subcellular 
compartments (pumps) (Berridge M.J. et al., 2003). Eukaryotic cells may  manage 
and sequester Ca2+ into intracellular organelles, mainly  in the endoplasmic 
reticulum (ER) and the Golgi apparatus (GA), but also peroxisomes, 
mitochondria and endolysosomal compartments (Fig. 1) (Prins D. and Michalak 
M., 2011). Changes in intracellular [Ca2+], caused by its influx from the 
extracellular medium or release from intracellular stores, may  trigger different 
cellular events, such as exocytosis, muscle contraction, fertilization and 
transcription activation. 
1.1. Intracellular Ca2+ stores and dynamics
Ca2+ may be compartmentalized within subcellular endomembrane compartments, 
accumulating or releasing Ca2+ and also by  shaping its transients. The main Ca2+ 
store is the ER, but also the GA, mitochondria, peroxisomes and endolysosomes 
are strictly involved in Ca2+ signalling (Pozzan T., et al., 1994; Rizzuto R. and 
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Pozzan T., 2006). Each organelle has its own distinct Ca2+ molecular toolkits and 
Ca2+ handling proprieties (Zampese E. and Pizzo P., 2011).
1.1.1 The Endoplasmic Reticulum
The ER is a complex and continuous membrane network, with a luminal space 
that may comprise up to 10% of the whole cell volume. The ER is involved in 
many different pathways such as carbohydrate and steroid metabolism, 
biotransformation and protein processing (Csala M. et al, 2006).
In many  cell types, increases in cytosolic [Ca2+] can be mainly due to the release 
of Ca2+ from the ER. 
The ER contains a high intra-luminal [Ca2+] that has been measured with 
different metodologies in different cell types, from 200 µM up to 1mM 
(Meldolesi J. and Pozzan T. 1998).
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Fig. 1: Ca2+ signalling, dynamics and homeostasis.
This compartment contains several proteins able to regulate molecular trafficking 
from and toward the ER (proteins, ions, etc.), regulated, in their role, by  the fine 
control of [Ca2+]. 
Ca2+ accumulation by the ER depends on the activity of SERCAs (Sarco/
endoplasmic reticulum calcium ATPases): a family  of transmembrane proteins 
that can pump actively 2 Ca2+ ions in the ER lumen exploiting the energy  of one 
molecule of ATP (Wuytack F., et al., 2002). In mammals three genes (ATP2A1, 
ATP2A2, ATP2A3) are present encoding the three SERCA proteins, that have 
also different splicing variants. There is a different tissue-specific expression 
pattern of the SERCA variants that can also change during development. The 
SERCA2b is almost ubiquitous and it is considered the housekeeping isoform 
(Brini M. and Carafoli E., 2009). There are several drugs able to inhibit the 
SERCAs, such as the irreversible inhibitor thapsigargin (Tg) (Thastrup O. et al, 
1990) and the reversible inhibitors cyclopiazonic acid (CPA) (Seidler N.W. et al, 
1989) and 2,5-di-(ter-butyl)-1,4-benzohydroquinone (t-BHQ) (Oldershaw K.A. 
and Taylor C.W.,1990).
Within the ER different Ca2+ buffering proteins are present, such as calreticulin 
(CRT), calnexin (CNX), calsequestrin (CSQ) (in the sarcoplasmic reticulum), 
glucose-related protein 78 (GRP78) and 94 (GRP94), etc. All these proteins have 
multiple Ca2+ binding sites but  with a low Ca2+ affinity (Kd about 1mM). These 
latter features provide a double advantage: buffering a large amount of Ca2+ and 
a rapid diffusion of the cation within the organelle and the consequent prompt 
release upon opening of Ca2+ releasing channels (Zampese E. and Pizzo P., 
2011).
Ca2+ is released from the ER through two main family of channels: the inositol 
1,4,5-triphosphate (IP3) receptor (IP3R), ubiquitously expressed, and the 
ryanodine (Ry) receptors (RyRs).
IP3 is a cell common second messenger which release is triggered by different 
extracellular stimuli (hormones, growth factors, neurotransmitters, etc) that bind 
and activate plasma membrane G-coupled protein receptors. These latter 
proteins, in turn, activate the phospholipase C (PLC) that acts on phosphatidyl 
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inositol bis-phosphate (PIP2) producing two distinct second messengers: IP3 and 
diacyl-glycerol (DAG) (Fig. 2).
IP3 diffuses in the cytoplasm and binds to IP3R, ligand-gated Ca2+ release 
channels, localized primarily in the ER membranes (Maeda N. et al., 1991). The 
activation of the channel induces a rapid flux of Ca2+ from the ER lumen to the 
cytosol and, as a second effect, increases its Ca2+ sensitivity. Indeed, Ca2+ itself 
is the most  important modulator of the IP3R which shows a biphasic modulation: 
at low cytosolic [Ca2+] (250-300 nM) the channel is activated,  potentiating the 
IP3 response, while at higher concentration (>10 µM), occuring upon Ca2+ release 
at receptor close proximity, the channel is blocked (Foskett J.K. et al, 2007).
The activity of the IP3R may also be modulated through phosphorylation by 
different kinases (PKA, PKC, etc.) (da Silva C.P. and Guse A.H., 2000) or 
interaction with different intraluminal (Chromogranin, ERp44, etc.) and 
cytosolic (Huntingtin, Cytochrome c, etc.) proteins (Choe C.U. and Ehrlich B.E., 
2006).
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Fig. 2: Molecular mechanisms of IP3 and DAG second messengers cascade activation 
 (Principles of Biochemistry, 4/e. Pearson Prentice Hall, Inc. 2006).
To date, in mammalian cells, IP3Rs are known to be coded by three different 
genes with different alternative spliced isoforms. The sequences of the three 
genes have an homology of approximately 60–80%. Different  cells have distinct 
and overlapping IP3R patterns of expression that vary during differentiation and 
they can express more than one isoform (Foskett J.K. et al., 2007). The different 
isoforms are probably involved in shaping different types of signalling events 
(Hattori M. et al., 2004).
An IP3R molecule contains: (I) a large cytoplasmic N-terminus (~85% of the 
protein), that  includes the IP3 binding region (Mignery G.A. et al., 1990) and a 
“regulatory”/“coupling” domain which has phosphorylation sites and binding 
sites for nucleotides and proteins; (II) a central hydrophobic region that  forms 
six membrane-spanning helices that contribute to the ion-conducting pore of the 
channel; (III) a relatively  short cytoplasmic C-terminus that contains a 
suppressor domain, that may inactive the channel (Foskett J.K. et al, 2007).
The complete IP3R channel is a homo- or hetero-tetramer of four IP3R molecules 
(Joseph S.K. et al., 1997; Patel S. et al., 1999). In this tetrameric structure (Fig. 
3) the 5th and 6th helices of the tran-smembrane region and the cytosolic C-
terminus are critical for creating the basic pore structure (Michikawa T. et al., 
1994; Ramos-Franco J. et al., 1999). 
When IP3 binds the N-terminus of the channel, it induces conformational changes 
that activate the gate, enabling ions flow through the channel. The molecular 
identity of the gate and the mechanisms that couple ligand binding to the 
opening/closing of the gate are still unknown (Foskett K.J. et al., 2007).
As previously  described, the N-terminus cytoplasmic part of the protein contains 
the regulatory  domain, that integrates different cellular signalling pathways or 
metabolic states with the IP3R functionality (Zampese E. and Pizzo P., 2011).
Several molecules - such as homer, protein phosphatases (PP1, PP2A), RACK1, 
chromogranin, Na+/K+-ATPase, carbonic anhydrase-related protein (CARP) and 
IRBIT - interact with the IP3R and modulate its activity, suggesting that the 
receptor can form multi-molecular complexes and function as a centre for 
signalling cascades (Mikoshiba K., 2007).
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The other major Ca2+-releasing channel in the ER membranes is the RyR. RyRs 
are large conductance channels capable of creating rapid transient increases of 
cytosolic Ca2+. RyRs play  a vital role in muscle excitation–contraction (E-C) 
coupling. They release Ca2+ from the sarcoplasmic reticulum (SR) into the 
cytosol, which sets off a cascade of events resulting in muscle contraction (Lamb 
G.D., 2000). E-C coupling refers to the close interaction between the 
dihydropyridine receptor (DHPR) L-type Ca2+ channels and RyRs, where 
depolarization of the plasma membrane, due to L-type Ca2+ channels, is coupled 
to opening of RyRs (Beam K.G. and Bannister R.A., 2010).
Structurally, the RyR is a homotetramer of 2 MDa formed by monomer of ~ 5000 
amino acids. Most of the mass of the RyR, similarly to the IP3R, forms a large 
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Fig. 3: The IP3R Ca2+ release channel. The cartoon depicts three of four IP3R molecules (in 
 different colours) in the tetrameric structure. Part of the luminal loop connects 
 transmembrane helices 5 and 6 of each monomer creating the permeation pathway for 
 Ca2+ efflux from the ER lumen (Foskett J.K. et al., 2007).
cytoplasmic assembly that is connected to the trans-membrane region. The 
cytoplasmic region has distinctive structural domains and intervening cavities 
that permit the interaction with modulators (Fig. 4). The clamp-shaped regions, 
located at the corners of the cytoplasmic assembly, contain domains for the inter-
digitation of neighboring RyRs and for the interaction with some modulators 
(Hamilton S.L. and Serysheva I.I., 2008).
The RyR and the IP3R share an overall 17% sequence identity  and the identity 
increases up to 35% within the predicted transmembrane region of the two 
proteins. The two receptors show similarities in their function and regulation: 
indeed both permeate Ca2+ and are regulated by it  in a biphasic manner [Roderick 
H.L. et al., 2003]; structurally, both are trans-membrane proteins that share a 
high sequence homology in their ion-conducting pore (formed by  2 
transmembrane helices from any monomer of the receptor) and both have 
conserved domains outside the trans-membrane region (Ponting C.P., 2000).
While in skeletal muscle RyR1 opening is primarily (or exclusively) due to the 
E-C coupling with DHPR, the major gating mechanism of RyR2 and RyR3 is the 
Ca2+-induced Ca2+ release (CICR): in this case, the opening of RyRs is due to the 
local plasma membrane Ca2+ increase, occurring in the proximity of Ca2+ 
channels, as initially demonstrated for cardiac muscle cells (Fill M. and Copello 
J.A., 2002).
1.1.2 The Golgi Apparatus
The GA is the main sorting and processing site along the secretory pathway, 
ensuring that lipids and proteins synthesized in the ER are properly modified 
(e.g., glycosylated, phosphorylated, processed and packaged into carrier 
vesicles) and eventually  directed to their final destination within or outside the 
cell (P. Pizzo et al., 2011).
The GA can be schematically  viewed as a three composed organelles (cis-, 
medial- and trans-Golgi) and consists of multiple membranous cisternae 
arranged in close apposition forming multiple polarized stacks. Indeed, the GA 
has a cis-side associated with a tubular reticular network of membranes (cis-
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Golgi network, CGN), a medial area of disc-shaped flattened cisternae, and a 
trans-side associated with another tubular reticular membrane network (trans-
Golgi network, TGN) (fig. 5) (Pizzo P. et al., 2011).
The GA is a highly dynamic structure, where the steady-state structure of Golgi 
stacks depends on the balance of anterograde and retrograde vesicle trafficking 
between the various GA cisternae, the ER and other cellular compartments (P. 
Pizzo et al., 2011).
Functionally, the GA is an obligatory station for post-translational modification 
of proteins and lipids: it contains numerous glycosyl-transferases, glycosidases, 
sulphatases, kinases and pro-protein convertases (such as furin) that cleave 
protein precursors into their mature forms (Schafer W. et al., 1995).
The polarized morphology of GA parallels specific functionalities: for example, 
glycosyl-transferases act sequentially in consequent compartments and, in 
general, enzymes that need to act early in glycan biosynthetic pathways are 
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Fig. 4: The RyR macromolecular signalling complex
located within cis- and medial compartments of the GA, whereas enzymes that 
need to act later tend to reside within the trans-Golgi cisternae and the TGN 
(Breton C. et al., 2001).
In the last two decades, numerous direct and indirect evidence supported the idea 
that the GA plays a key role as intracellular Ca2+ store, containing up to 5% of 
whole cell Ca2+ (Chandra S. et al., 1991, Pezzati R. et al., 1991). Furthermore, 
processing enzymes located in the GA show a strong Ca2+ dependency  of their 
activity, such as retrograde membrane traffic from the Golgi to the ER (Oda K., 
1992) and selective aggregation of regulated secretory proteins in the TGN is 
also critically depended on GA Ca2+ content (Chanat E. and Huttner W.B., 1991).
The first direct demonstration that the GA is a dynamic Ca2+ store capable of 
releasing Ca2+ upon cell activation came when a new aequorin based Ca2+ probe 
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Fig. 5: Three-dimensional tomographic reconstruction of the Golgi complex. The cis-Golgi 
network (white) and the stack with the terminal three trans-Golgi cisternae (pink, red and 
cyan) are shown. The trans-Golgi network (violet) appears as a tubular network that emerges 
from the lateral part of the last trans-cisterna (cyan) (Pizzo P. et al., 2011)
specifically targeted into the GA lumen was developed (Pinton P. et al., 1998). 
With this tool was demonstrated that a high [Ca2+] is maintained in the GA lumen 
of a resting cell, and that the Ca2+ uptake in the GA is depended on the combined 
activity of two Ca2+ pumps: the SERCA pump typical of the ER, and the 
secretory pathway Ca2+ ATPase1 (SPCA1). Furthermore, Ca2+ within the GA 
could be discharged rapidly  and extensively upon stimulation with an IP3-
generating agonist. 
Experiments from different groups have confirmed that the GA is an ER-like 
Ca2+ store and indirectly supported the idea that its integrity is important for 
shaping cytosolic Ca2+ responses (Lin P. et al 1999; Callewaert G. et al., 2003). 
Furthermore, Ca2+ handl ing within the GA was demonstrated to be 
heterogeneous: Vanoevelen J. and Missiaen L. experiments showed that the 
SPCA1-containing Ca2+ sub-compartment was insensitive (or mildly sensitive) to 
IP3-generating agonist stimulations and therefore not involved in setting up 
cytosolic Ca2+ signals (Vanoevelen J. et al., 2004; Missiaen L. et al., 2004). 
The GA contains several Ca2+ handling proteins known to be expressed in the 
ER, such as SERCA2 pumps and IP3Rs (Pizzo P. et al., 2011); also RyRs have 
been shown to be expressed in this compartment (Cifuentes F. et al., 2001). 
For Ca2+ uptake, in addition to SERCA the GA expresses also another ATP-
dependent Ca2+ pump: the SPCA (Pizzo P. et al., 2011). In human cells, two 
different genes encoding for SPCA have been identified: ATP2C1 (that have 4 
protein variants) and ATP2C2.
SPCAs are single subunit integral membrane proteins with a large cytosolic head, 
containing an actuator (A), a nucleotide-binding (N), and a phosphorylation (P) 
domain, and with 10 hydrophobic trans-membrane helices (M1–M10).
Within the trans-membrane region, SPCAs contain one high-affinity  binding site 
for Ca2+ and Mn2+, providing both cations to the GA. This is a very important 
because Mn2+ is absolutely  required for the correct glycosylation of secretory 
proteins in the GA (Kaufman R.J. et al., 1994).
The GA is also equipped with luminal Ca2+-binding proteins. CALNUC is the 
most abundant and better characterized of the GA Ca2+ binding proteins (Lin P. et 
al., 1998). Other identified GA Ca2+ binding proteins are Cab45, a luminal 
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soluble protein  important for vesicular sorting (Scherer P.E. et al, 1996); p45/
NEFA, a luminal protein strongly  associated to GA membranes (Karabinos A. et 
al., 1996) and  calumenin, a protein present also in the ER and in the secretory 
pathway, that interacts with SERCA and RyR2 modulating their activity (Jung 
D.H. et al. 2006; Sahoo S.K. et al, 2009). 
The GA is thus equipped with all the necessary molecular components for its 
function as a Ca2+ store (Ca2+ pumps, Ca2+ releasing channels and luminal Ca2+-
binding proteins), and their differential distribution within GA cisternae suggests 
that the GA does not behave uniformly in terms of Ca2+ handling.
Recently, in our lab, direct evidence of the GA heterogeneity have been obtained, 
using a novel genetically  encoded fluorescent Ca2+ indicator specifically targeted 
to the trans-Golgi lumen, the GoD1cpv. With this probe, it has been 
demonstrated that within the trans-Golgi is present the only SPCA1 (and not the 
SERCA) to takes up Ca2+ and the release of Ca2+ does not happened in response 
to IP3 generation (Fig. 6A), rather, the cytoplasmic Ca2+ rise that follows this 
latter event, leads the trans-Golgi Ca2+ accumulation (Fig. 6B) (Lissandron V. et 
al., 2010). 
Furthermore, cells that express high level of RyRs (i.e., neonatal primary 
cardiomyocytes) showed, upon activation of these latter channels by  caffeine or 
in response to CICR, a release of Ca2+ within the trans-Golgi (fig. 6C) 
(Lissandron V. et al., 2010).
From these findings is clear that the trans-Golgi appears as an intracellular Ca2+ 
store quite distinct from the ER, but also from the other GA sub-compartments.
In cells that do not express RyRs, the trans-Golgi behaves simply as a Ca2+ sink, 
taking up  Ca2+ by SPCA1 when cytosolic Ca2+ increases, while it represents a 
mobilizable Ca2+ store when RyRs are functionally present, for example in 
cardiomyocytes (Lissandron V. et al., 2010).
The [Ca2+] within the trans-Golgi, calculated in HeLa cells using the GoD1cpv, 
is 130 µM  (Lissandron V. et al., 2010), lower than the [Ca2+] measured with 
aequorin in the whole GA of the same cell type (around 200–300 µM) (Pinton P. 
et al., 1998). Considering the data of several other groups showing the Ca2+ 
values calculated for the different intracellular organelles (with different probes 
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and in different cell types), it appears that a gradient in the luminal Ca2+ 
concentration through the secretory pathway is present. This gradient  decreases 
from the ER (3–400 µM), passing across the whole GA (200–300 µM) and the 
trans-Golgi (130 µM), to the secretory vesicles (80 µM) (fig. 7) (Lissandron V. 
et al., 2010; Pinton P. et al., 1998; Mitchell K.J. et al., 2001; Pizzo P. et al., 
2011).
The complexity of the GA morphology, and of its sub-compartments specific 
enzymatic repertoire, is paralleled by  the expression of different  molecular Ca2+ 
toolkit  in each sub-compartment (Ca2+ pumps, channels and buffering proteins). 
The informations on the cis- and medial-Golgi are still based on indirect data and 
one  attained goal of my work has been to characterize them, in term of Ca2+ 
handling, using specific targeted Ca2+ probes for these sub-compartments. 
Pag. 16
Fig. 6: A representative transGo-D1cpv FRET change curve in response to different stimuli 
 (panel A) and a representative Ca2+ refilling kinetic of the trans-Go (panel B) in HeLa 
 cells. Trans-Golgi Ca2+ response in cardiac myocytes upon ryanodine receptor 
 stimulation (panel C) (Lissandron V. et al., 2010).
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1.1.3 Mitochondria, peroxisomes and lysosomal compartments
Mitochondria are cellular organelles responsible of the generation of energy; 
moreover, they are also important intracellular Ca2+ modulators. The organelle 
can take up  Ca2+ in his matrix by the action of the uniporter (mitochondrial Ca2+ 
uniporter, MCU) that transports  Ca2+ at the cost of the high electrochemical H+ 
gradient across the mitochondrial membrane (ΔΨ ~ -180 mV) generated by  the 
respiratory chain (De Stefani D. et al., 2011). Within the mitochondrial matrix 
Ca2+ is stored not bound to Ca2+ buffering proteins but  instead precipitated out as 
an insoluble salt, CaPO4. The handling of Ca2+ by mitochondria is very complex, 
and one worth highlighting aspect is how mitochondria communicate with the ER 
with respect to Ca2+ fluxes (Prins D. and Michalak M., 2011).
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Fig. 7: Ca2+ concentration and molecular tool-kit gradient through the secretory pathway 
 (P. Pizzo et al., 2011).
Mitochondrial [Ca2+] has been accurately  measured evidencing that, upon an 
agonist-evoked transient cytosolic [Ca2+] increase, mitochondria respond with a 
transient Ca2+ increase that reaches values even 100-fold higher than the 
cytosolic one (Rizzuto et al, 1992). These evidence led to the hypothesis that ER 
and mitochondria are often tightly  apposed in regions known as mitochondria-
associated membranes (MAM), where [Ca2+] can reach very high levels, as in the 
proximity of IP3-sensitive channels (Rizzuto et al., 1993). Interestingly, resting 
cytoplasmic Ca2+ levels promote dissociation of the two organelles whereas 
higher Ca2+ levels enhance their association, suggesting that mitochondria may 
act as buffers to soak up Ca2+ released from the ER lumen (Wang et al., 2000). 
Ca2+ entry into mitochondrial matrix exerts different physiological functions 
ranging from activation of three mitochondrial dehydrogenases (the pyruvate, α- 
keto-glutarate and isocitrate dehydrogenase), thus positively regulate ATP 
synthesis, to obtain buffering and modulation of cytosolic Ca2+ variations 
(Giacomello et al., 2007).
Recent results indicate that peroxisomes are capable of taking up  and storing 
Ca2+ within their lumen at concentrations much higher than those found in the 
cytoplasm (Raychaudhury  B. et al. 2006; Drago I. et  al. 2008). However, it is not 
yet  known how Ca2+ is stored within these organelles and whether specific 
peroxisomal Ca2+ buffering proteins exist (D. Prins and M. Michalak, 2011). 
Recently, the nicotinic acid adenine dinucleotide phosphate (NAADP) has been 
shown to act as a second messenger, mobilizing intracellular Ca2+ stores by 
activation of two-pore channels (TPCs) in endosomal membranes (Calcraft P.J. et 
al. 2009). Endosomes and lysosomes may thus be considered as Ca2+ storage 
organelles; however, the mechanism of lysosomal Ca2+ buffering has not been yet 
described (D. Prins and M. Michalak, 2011).
1.2 Extracellular Ca2+ entry into cells
A cytosolic [Ca2+] rise can trigger a fast  activation of different signalling 
pathways; these [Ca2+] increases can be due to the opening of Ca2+ channels, 
located on the plasma membrane or within organelles membranes, allowing Ca2+ 
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to follow its electrochemical gradient. Most ion channels are gated (i.e., capable 
of making transitions between conducting and non-conducting conformations), 
permitting their activation upon an appropriate electrical or chemical stimuli. 
Ca2+ channels have generally been classified on the nature of the activation 
stimulus in voltage-gated and ligand-gated Ca2+ channels (Piertrobon et al., 
1990; Fasolato et al., 1994).
1.2.1 Voltage-operated Ca2+ entry
Voltage-operated Ca2+ channels (VOCCs) can be opened upon plasma membrane 
depolarization, transforming electrical signals into chemical signals. In the 
nervous sys tem they cont ro l a b road a r ray of func t ions inc lud ing 
neurotransmitter release, neurites outgrowth, synaptogenesis, neuronal 
excitability, differentiation, plasticity, etc. VOCCs are present also in other cell 
types, such as cardiac and smooth muscle cells, where their activation initiate 
contraction directly by  increasing cytosolic [Ca2+] and indirectly  by activating 
CICR by RyRs in the SR (W.A. Catterall, 2011); in skeletal muscle cells, where 
these channels interact directly  with RyRs within the SR and activate them to 
initiate rapid contraction (Catterall W.A., 1991); in endocrine cells, where 
VOCCs mediate Ca2+ entry that initiates secretion of hormones (Yang S.N. and 
Berggren P.O., 2006).
VOCCs are multi-subunits complexes made up of a pore-forming and voltage-
sensing α1 subunit and several auxiliary  subunits, including 2δ and β subunits 
and, in some cases, also γ subunits. They constitute a complex family of channels 
comprising a larger number of different subtypes, which have in common a steep 
voltage dependence of the open probability  and a very  high selectivity for Ca2+ 
over Na+ and K+ ions in physiological solution (Carafoli 2005). They  are located 
in the plasma membrane in excitable cells (e.g., in neurons and heart cells), and 
are classified in different subtypes depending on voltage and inhibitors 
sensitivity: L-, N-, T-, P/Q-, and R- type.
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1.2.2 Ligand-operated Ca2+ entry
Ligand-gated Ca2+ channels are characterized by a lower selectivity for Ca2+ over 
other monovalent cations if compared to VOCCs. This family  of Ca2+ channels is 
usually divided  into two  subgroups:
1- The receptor-operated Ca2+ channels, which possess a ligand-binding site in 
the same polypeptide or in the same molecular complex forming the channel 
i t se l f . The ex t race l lu la r b ind ing of the l igand , e i the r hormone or 
neurotransmitter, may trigger channels opening and the further Ca2+ entry 
(Clapham 2007).
3- Second-messenger Operated Ca2+ channels, which are activated by  second 
messengers produced or released after activation of G-protein or enzyme-coupled 
receptors. The most common second messengers are: cAMP, cGMP, IP3, DAG, 
arachidonic acid and Ca2+ itself (Clapham 2007).
1.2.3 Store-operated Ca2+ entry
Depletion of intracellular Ca2+ stores via different way, such as Ca2+ release 
associated to the IP3 cascade or by the inhibition of SERCA pump, results in the 
activation of Ca2+ influx via the so-called store-operated Ca2+ channels (SOCCs) 
(Vaca L., 2010), that may re-establish the Ca2+ content of the stores depleted and 
resets the system.
One key event in this process is the signal that communicate the depleted state of 
intracellular Ca2+ stores to the plasma membrane channels (Putney J.W. Jr., 
2007). STIM1 is the molecular link between the ER Ca2+ depletion event and the 
store-operated Ca2+ entry activation that, in turn, depends on the activation of 
Ca2+ release-activated Ca2+ (CRAC) channels in the plasma membrane.
STIM1, initially characterised as a phosphoprotein, includes a single 
transmembrane domain located in the ER in resting cells. Within the N-terminal, 
the luminal part of the protein, a single EF-hand Ca2+-binding motif acts as 
luminal ER Ca2+ sensor (Liou J. et al., 2005). 
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The direct CRAC molecular interactor of STIM1 is Orai1 that comprise the 
CRAC channel pore-forming subunit  (Cahalan M.D., 2009). Orai1 is formed by 
four trans-membrane segments that form the Ca2+ selective plasma membrane 
channel (Cahalan M.D. et al., 2005). 
In resting cells, STIM1 is uniformly  distributed within the ER membrane, 
displays tubular structures and binds to the microtubule-plus-end-tracking 
protein EB1 at those sites where microtubule ends come in contact with the ER 
(fig. 8) (Grigoriev I. et  al, 2008). After sensing the Ca2+ depletion within the ER, 
STIM1 forms oligomers and then redistributes into punctuate clusters close to 
the plasma-membrane (fig. 8) (Liou J. et al., 2005). Recently, it has been shown 
that oligomerisation of about  four STIM1 proteins is the critical step transmitting 
ER store depletion to activating store-operated Ca2+ entry  (fig. 8). In particular, 
four Orai1 molecules create the pore-forming subunit of the CRAC channel that 
opens upon stimulation by STIM1, upon the interaction of the C-terminus of 
STIM1 and N-terminus of Orai1  (fig. 8) (Lewis R.S., 2007).
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Fig. 8: The functional units of store-operated Ca2+ entry assemble in response to store 
 depletion (Saboloff J. et al., 2011).
2. Genetically encoded Ca2+ sensors
As explained in privious section, Ca2+ is one of the most important cellular 
second messangers, and the development of tools and methods to valuate Ca2+ in 
living cells became crucial in last decades for the study of this molecule.
Up to now several probes have been devised, which are classifiable in chemical 
(or synthetic) Ca2+ sensors (such as quin-2, fura-2, fluo-4, calcium green, etc) 
and genetically encoded Ca2+ indicators (GECIs).
This latter class are defined as indicators that are produced by translation of a 
nucleic acid sequence and they are composed solely  of natural protein or peptide 
motifs. In order to convert a Ca2+ signal into an optical readable signal, GECIs 
consist  of at least one light-emitting protein and a Ca2+ responsive element, 
where Ca2+ binding changes the optical properties of the protein(s). These 
protein-based indicators are typically incorporated into cells by gene transfer 
techniques (McCombs J.E. and Palmer A.E., 2008).
GECIs have the intrinsic advantage that they  may be targeted to specific 
intracelular site and organelles (such as mitochindria, ER, GA, etc), just adding a 
specific targeting sequence at one or both protein ends.
This class of Ca2+ sensors comprise three main sub-groups (Fig. 9): 
1- bioluminescent reporters. This group of GECIs, based on the aequorin 
photoprotein (Rizzuto R. et  al., 1994), are able to generate light by a chemical 
reaction that requires reconstitution of the indicator with a co-factor 
(coelenterazine);
2- single fluorescent proteins indicators. These probes are composed by a Ca2+-
responsive elements, such as calmodulin (CaM), or a portions of it, which are 
inserted into a fluorescent  protein (FP). Ca2+ binding alters the protonation state 
of the FP changing the spectral properties of the chromophore. These indicators 
include the camgaroos, G-CaMPs, pericams, “Case” sensors and grafted EF-
hands (McCombs J.E. and Palmer A.E., 2008);
3- FRET-based sensors. Substancially, this group is composed solely  by  the 
“cameleon-type” probes, in which a Ca2+-responsive elements are inserted 
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between two fluorescent proteins. Upon Ca2+ binding, an alteration in the 
efficiency of fluorescence resonance energy  transfer (FRET) occurs (Miyawaki 
A. et al., 1997).
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Fig. 9: Models of the three sub-groups of GECIs.  (a) The aequorin photoprotein is shown in 
 complex with coelenterazine. Upon Ca2+ binding it undergoes a conformational change 
 emitting blue light with the  release of coelenteramide; (b) single FP sensors which 
 employ CaM and a CaM binding peptide (M13) linked to a FP. Upon Ca2+ binding 
 CaM-M13 induce a conformational change that alter the chromophore protonation state 
 which result in a changing of the probe fluorescence intensity; (c) grafted sensors 
 utilizing EF hands or portions of CaM inserted into a fluorescent protein. Binding of 
 Ca2+ induces a change in the protein conformation and a shift in the protonation state of 
 the chromophore; (d) in FRET-based probes a Ca2+ binding domain is located between 
 two fluorescent proteins. In presence of Ca2+, the Ca2+ binding domain change its 
 conformation that brings the two FPs close enough to increase the FRET efficiency 
 (McCombs J.E. and Palmer A.E., 2008). 
2.1 FRET-based cameleon probes
Cameleons (fig. 9) are tandem repeats of GFP mutants with overlapping 
excitation/emission spectra linked together by a Ca2+ sensor based on CaM, a 
glycyl-glycine linker, and the CaM  binding peptide of myosin light chain kinase 
M13 (M13) (Miyawaki A. et  al., 1997). In this design, Ca2+ binding promotes the 
reversible association of CaM  and M13, promoting fluorescence resonance 
energy transfer between the two GFP variants (Demaurex N., 2005).  
The first  probes generated, yellow cameleons (YC), used cyan and yellow 
fluorescent proteins (CFP and YFP) as FRET donor and acceptors. The reversible 
changes in FRET can be detected as changes in the yellow over cyan emission 
fluorescence, and the probes function as ratiometric emission Ca2+ indicators. 
The original YC comprised probes of different affinities, ranging from 1 to 
300µM (YC2, YC3 and YC4), but all probes suffered from a poor dynamic range 
and were sensitive to pH and to chloride ions. YC were subsequently made pH 
resistant by YFP mutagenesis (YC2.1 and YC3.1) and brighter by replacing YFP 
with citrine (YC3.3) or with Venus, a YFP mutant with fast and efficient 
maturation (YC2.12 and VC6.1). Although these cameleons were greatly 
improved over the original design, they still displayed insufficient signal-to-
noise ratio when targeted to organelles (Demaurex N., 2005).
To further increase the dynamic range of cameleons, Nagai et  al. generated 
several circularly  permuted YFP mutants in an attempt to optimize the relative 
orientation of the two FRET partners (Nagai T. et al., 2004). By introducing new 
termini into the surface exposed loop regions of the β-barrel of Venus, they 
generated several YC variants with improved dynamics. The best construct, YC 
3.6, which contains a YFP circularly permutated at position 173 (173cpVenus), 
matures efficiently, is resistant to acidification, and displays a monophasic Ca2+ 
sensitivity with a Kd of 250 nM. The cp173Venus cameleon has much better 
dynamics than all previous cameleons when expressed in cells, with an 
impressive 5.6-fold increase in ratio between Rmin and Rmax. The expanded 
dynamic range of YC3.6 is a clear advantage to image Ca2+ dynamics in cells and 
tissues with adequate spatiotemporal resolution.
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Moreover A.E. Palmer et al. generated a series of indicators that resist 
endogenous CaM and have varying Ca2+ affinities to be useful in monitoring Ca2+ 
in distinct subcellular locations as well as in microdomains of high Ca2+ (Palmer 
A.E. et al., 2006). Their goal in redesigning the cameleon was to reengineer the 
binding interface between CaM and a target peptide to generate selective and 
specific binding pairs that could not be perturbed by wild-type (wt) CaM. They 
previously reversed the salt bridge interactions between basic residues in the 
target peptide and acidic residues in CaM to generate a mutant calmodulin-
peptide pair that was unaffected by large concentrations of excess CaM. This 
redesigned pair led to a Ca2+ indicator (D1) with a relatively weak affinity for 
Ca2+ (Kd = 60 µM) and has been used to monitor Ca2+ directly  in the ER in 
individual living cells (Palmer A.E. et al., 2004).
Subsequently, they computationally designed steric bumps in the target peptide 
and complementary holes in CaM in order to generate a series of indicators (D2, 
D3, and D4) with varying Ca2+ affinities (fig. 10), including a high-affinity 
indicator that cannot be perturbed by excess CaM. These indicators show 
significant improvements in the ability to monitor Ca2+ in different subcellular 
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Fig. 10: In Vitro Characterization of the Redesigned Cameleons Ca2+ titration curves of original 
 and redesigned cameleons. The original cameleons (YC2, YC3, and YC4; black 
 diamonds) are labeled on the graph. The first redesign, D1, is presented as red circles, 
 and the computational designs are presented as follows: D2cpv, blue squares; D3cpv, 
 green, upside-down triangles; D4cpv, purple triangles.
locations such as the plasma membrane of neurons and the mitochondria (Palmer 
A.E. et al., 2006).
To date, cameleons have been targeted the cytosol (D1cpv probe) (Leite M.F. et 
al., 2003), the ER (ER-D1 probe), the nucleoplasm (H2BD1cpv probe) (Leite 
M.F. et al., 2003), to the mitochondria (4mt-D1cpv probe) (de Brito O.M. and 
Scorrano L., 2008), to the trans-Golgi (Go-D1cpv probe) (V. Lissandron et al., 
2010), to the peroxisomal matrix (KVK-SKL-D3cpv probe) (Schrader M. and 
Yoon Y., 2007).
All these probes have been successfully used to monitor Ca2+ dynamics in their 
specific sub-cellular compartments.
3. The Alzheimer’s disease
Alzheimer’s disease (AD) was first described little more than 100 years ago. It is 
the most common cause of dementia with an estimated prevalence of 30 million 
people worldwide, a number that is expected to quadruple in 40 years.
In the 105 years since Alzheimer’s original case report and particularly in the 
past three decades, much has been learned about Alzheimer’s disease (AD). 
However, there currently is no effective treatment that delays the onset or slows 
the progression of AD (Holtzman D.M. et al., 2011).
3.1. Clinical and pathological features of AD
Dementia is an acquired syndrome characterized by a loss or decline in memory 
and other cognitive abilities. It represents a decline from a person’s previously 
established level of intellectual function that is sufficient to interfere with the 
everyday performance of that individual. AD is the most common cause of 
dementia, estimated to contribute to about 60–70% of cases (Barker W.W. et al., 
2002).
The essential feature of AD, intra-individual decline in cognitive abilities, has an 
insidious onset over several months with subsequent gradual but relentless 
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progression though successive stages of dementia severity. The time course of 
AD dementia averages 7–10 years and inevitably the illness culminates in death. 
Impaired recent memory usually is an initial symptom of AD but other cognitive 
deficits, such as executive dysfunction manifested by  changes in attention and 
problem solving abilities, are typically  also present. As dementia progresses, 
language dysfunction, visuospatial difficulty, loss of insight, and personality 
changes (withdrawal, decreased initiative, occasionally  depression) frequently 
are apparent. There also is impaired ability  to function at routine tasks at home, 
such that even basic activities of daily living (e.g., dressing, bathing, grooming) 
require supervision or assistance. In the severe stage of Alzheimer dementia, 
individuals are totally dependent on caregivers for all activities of daily living 
and, in advanced disease, often become mute, non-ambulatory, and unable to 
swallow or control bladder and bowel function (Holtzman D.M. et al., 2011).
The key neuropathological elements of AD were described by Alois Alzheimer in 
1906 and at about the same time by  Oskar Fischer (Goedert M., 2009). At the 
macroscopic level, there is abundant atrophy of the brain (Figure 11).
Amyloid plaques are accumulations of molecules in the extracellular space of the 
brain (fig. 12). The principal proteinaceous component of this plaques is the 
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Fig. 11: Postmortem brain section from an AD case (left) compared with that of a cognitively 
  normal individual (right).
amyloid-β (Aβ) peptide, a 38–43 amino acid peptide derived from a much larger 
protein, the amyloid precursor protein (APP). Within plaques, Aβ is present in 
aggregated (insoluble) forms including fibrils as well as oligomers (Kayed R. et 
al., 2003).
These “neuritic” plaques are surrounded by swollen, degenerating neurites 
(axons and dendrites). In areas surrounding neuritic plaques, there is also 
“gliosis” with hypertrophy and an alteration of the morphology as well as the 
proliferation of astrocytes and microglia (immune cells of the CNS). It  is likely 
that this inflammatory response contributes to brain injury although there is 
evidence that glial cells also play a protective role (Lucin K.M. and Wyss-Coray 
T., 2009) (fig. 13).
In addition to the deposition of Aβ in plaques in AD, nerve cell bodies as well as 
their processes in specific brain regions develop neurofibrillary  tangles (NFTs) 
(fig. 12), neuropil threads, and neuritic dystrophy (Braak H. and Braak E., 1997). 
NFTs (present in neuronal cell bodies) and neuropil threads (present in neuronal 
processes) are intracel lular s t ructures composed predominant ly  of a 
hyperphosphorylated, aggregated form of the microtubule binding protein, tau. 
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Fig. 12: The neurofibrillary tangles and tha amyloid plaques depositions in AD neurons.
Tau is synthesized and produced in all neurons and is also present in glia. The 
normal function of tau is to bind to tubulin and stabilize microtubules. However, 
in AD, tau becomes hyperphosphorylated and this form of tau disassociates from 
microtubules and has a tendency to self-aggregate forming NFTs in cell bodies 
and dystrophic neurites.
Data strongly suggest  that neurofibrillary pathology contributes to neuronal 
dysfunction and correlates with the clinical progression of AD (Holtzman D.M. 
et al., 2011).
Clinically, most cases of symptomatic AD begin after age 65 years with 
incidence increasing with age. These cases are often referred to as “sporadic” or 
“late-onset” AD (LOAD). This form of AD accounts for >99% of all cases. In 
addition to LOAD, a very small percentage (<1%) of AD occurs within families 
and is inherited in an autosomal dominant fashion and are termed FAD. In these 
families, dementia onset is usually between the ages of 30–60  years. APP was 
identified as the first gene in which mutations in the coding sequence cause FAD 
(Levy E. et  al., 1990). These mutations within the APP gene provided an 
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Fig. 13: Diagram illustrating aspects of the neuropathology of AD.
important clue regarding the likely mechanism leading to increased Aβ 
accumulation in the brain in FAD.
In addition to APP, mutations in 2 other genes have been identified in which 
specific mutations result  in the rare, autosomal dominant forms of FAD: 
presenilin-1 (PS1) (Levy-Lahad E. et al., 1995) and presenilin-2 (PS2) 
(Sherrington R. et  al., 1995). These genes encode highly homologous 
transmembrane proteins in which multiple mutations have been identified in FAD 
families. Mutations in PS1 are the most common identified cause of FAD. 
A molecular connection between presenilins and Aβ production was uncovered in 
the late 1990s. A normal function of presenilins is to form a γ secretase complex 
with 3 other proteins, Anterior pharynx-defective1 (APH-1), Presenilin enhancer 
2 (PEN2), and nicastrin (Takasugi N. et al., 2003). The γ secretase complex 
directly cleaves the transmembrane protein Notch, APP, and other substrates, and 
its activity is required for Aβ formation (Holtzman M.D. et al., 2011). 
Thus, AD is thought to be a disorder of protein aggregation in which the 
aggregation and accumulation in the brain of Aβ and tau are key players in AD 
pathophysiology. However, there are many additional cellular pathways, 
processes, and molecules involved in AD pathogenesis that have emerged and 
will continue to be discovered, that play important roles in the disease (Holtzman 
D.M. et al., 2011).
3.2. Molecular causes of AD
The pathogenesis of AD is complex and involves many molecular, cellular and 
physiological phenomenon, firstly  the accumulation of β amyloid and the 
hyperphosphorilation of tau. Although for many years ‘Aβ-centric’ hypotheses 
dominated AD research (Pritchard S.M. et al., 2011), the importance of tau in the 
pathogenesis of AD is now much more appreciated (Small S.A. and Duff K., 
2008), and seems to increase as new findings emerge. In addition, the calcium 
hypothesis support the proposal of an early, central role of calcium dysregulation 
in the pathogenesis of AD.
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3.2.1. The amyloid hypothesis
The amyloid plaques associated with AD were first purified and found to consist 
of multimeric aggregates of Aβ polypeptide containing about 40 amino acid 
residues in the mid-1980s (Glenner G.G. and Wong C.W., 1984).
Cloning of the complementary DNA (cDNA) of Aβ revealed that Aβ is derived 
from a larger precursor protein (Tanzi R.E. et al. 1987). The full-length cDNA of 
APP was later isolated and sequenced and it was predicted to be a glycosylated 
integral membrane cell surface receptor protein with 695 amino acids (Kang J. et 
al., 1987).
The Aβ peptide was found to be a cleavage product derived from the 
transmembrane domain of this large precursor protein, the APP.
The APP protein is a type I integral membrane protein with a large extracellular 
portion, a hydrophobic transmembrane domain, and a short C-terminus 
designated the APP intracellular domain (AICD).
APP undergoes post-translational processing, involving several different 
secretases and proteases, via two major pathways. 
In the non-amyloidogenic pathway, APP is sequentially cleaved by α-secretase 
and γ-secretase. α-cleavage, which cuts APP at the 17th amino acid inside the Aβ 
peptide sequence (fig. 14), releases a large secreted extracellular domain (sAPP-
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Fig. 14: Proteolytic processing of APP
α) and a membrane-associated C-terminal fragment consisting of 83 amino acids 
(C83). APP C83 is further cleaved by  γ-secretase to release a P3 peptide and the 
AICD, both of which are degraded rapidly (Zhang H. et al., 2012). 
In the amyloidogenic pathway, APP is primarily  processed by β-secretase at the 
first residue or at the 11th residue (so called β’ site) of the Aβ peptide sequence 
(fig. 14), shedding sAPPβ and generating a membrane associated C-terminal 
fragment consisting of 99 amino acids (C99) (Cole S.L. and Vassar R., 2007).
γ-Secretase further cleaves C99 to release AICD and the amyloidogenic Aβ 
peptide which aggregates and fibrillates to form amyloid plaques in the brain.
As APP was found to be constitutively cleaved at the α-site to yield sAPP-β, 
three members of the α disintegrin and metalloproteinase (ADAMs), ADAM-10, 
ADAM-17 and ADAM-9 have been proposed as the α-secretase (Koike H. et al. 
1999).
ADAMs are type I integral membrane proteins that belong to the zinc protease 
super family and have been implicated in the control of cytokine and growth 
factor shedding.
ADAM10 is widely expressed in the brain and in other tissues and a several fold 
increase in sAPP-β levels in cell lines overexpressing ADAM10 can be observed 
(Kojro E. et al. 2001).
Moderate neuronal over-expression of human ADAM10 increases sAPP-β 
production while reducing Aβ generation/plaque formation in mice carrying the 
human APP V717I mutation, while expression of a catalytically-inactive form of 
the ADAM10 mutation increases the size and number of amyloid plaques in 
mouse brains (Postina R. et  al. 2004). These findings suggest that ADAM10 may 
be responsible for constitutive α-cleavage activity. However, although sAPP-β 
generation is not affected in ADAM9/17 knock-down cell lines nor in mice 
carrying deficient ADAM9/17 genes, over-expression of ADAM9/17 does 
increase the level of sAPP-α under some conditions, suggesting that ADAM9 and 
ADAM17 are more likely involved in the regulated β-cleavage of APP rather 
than in constitutive α-cleavage (Zhang H. et al, 2012).
Aβ generation is initiated by β-cleavage at the ectodomain of APP, resulting in 
the generation of an sAPP-β domain and the membrane associated APP C-
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terminal fragment C99. The putative β-secretase, β-site APP cleaving enzyme 1 
(BACE1), was first identified and characterized in 1999 (Sinha S. et al., 1999). 
BACE1 is a type I transmembrane aspartyl protease with its active site on the 
luminal side of the membrane. The originally identified full length BACE1 has 
501 amino acids (BACE1-501) and is predominantly expressed in perinuclear 
post-Golgi membranes, vesicular structures throughout the cytoplasm, as well as 
on the cell surface (Ehehalt R. et al., 2002).
Knocking out  the BACE1 gene prevents Aβ generation and completely abolishes 
Aβ pathology in mice expressing the Swedish mutation of human APP (Cai H. et 
al. 2001). The expression level and activity of BACE1 were also found to be 
elevated in AD patients (Holsinger R.M. et al. 2002). 
Both α-cleavage and β-cleavage generate short APP C-terminal fragments that 
are further processed by γ-secretase.
Distinct from α-/β-secretases, γ-activity  involves a large proteinase complex (fig. 
15) consisting of at least four major protein components (PS1 or PS2, PEN2, 
APH1 and Nicastrin) (Vetrivel K.S. et al. 2006).
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Fig. 15: The γ-secretase complex
Presenilins (PSs) were identified and cloned in the mid-1990s (Levy-Lahad E. et 
al., 1995; Sherrington R. et al., 1995).
Genetic mutations of PSs are found in a large portion of FAD cases, indicating 
its crucial role in AD. Although other proteins are required for the γ-secretase 
complex, PSs are believed to contain the actual protease activity  (Zhang H., 
2012). 
PSs (fig. 16) are multi-transmembrane proteins and can be cleaved at the 
cytoplasmic loop between the sixth and seventh transmembrane regions to 
generate an N-terminal and a C-terminal fragment during post-translational 
maturation (Thinakaran G. et al., 1996). The two fragments interact with each 
other after the cleavage and they are both necessary for γ-secretase activity.
Nicastrin, identified as a protein that interacts with PS in 2000 (Yu G. et al., 
2000), is a type I membrane glycoprotein with a large ectodomain. Nicastrin 
undergoes a glycosylation/maturation process that causes a conformation change 
in its ectodomain, which is crucial for the assembly and maturation of the γ-
secretase complex and γ-activity. Mature nicastrin can bind to the ectodomain of 
APP C-terminal fragments derived through α-/β-secretase cleavage and may act 
as a substrate receptor of γ-secretase (Shirotani K. et al. 2003).
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Fig. 16: Schematic representation of Presenilin
PEN2 and APH1 are another two γ-secretase complex components that were 
originally identified as the enhancers of PSs (Francis R. et al., 2002). 
APH1 is a multiple transmembrane protein with seven transmembrane domains 
and a cytosolic C terminus. APH1 interacts with immature nicastrin and PS to 
form a relatively stable pre-complex which is then translocated to the trans-
Golgi from the ER/cis-Golgi for further maturation (Lee S.F. et al., 2002). 
PEN2 is a hairpin-like protein with two transmembrane domains and with both 
ends in the lumen. PEN2 is found to mediate the endoproteolysis of PS (Luo W.J. 
et al., 2003). 
γ-Secretase cleaves APP at multiple sites and in sequential steps to generate Aβ 
peptides of different lengths (fig. 14).The majority of Aβ peptides produced are 
40 amino acids long, however, peptides ranging from 38 to 43 amino acids are 
found in vivo. Besides the dominant γ-cleavage site at 40 and 42 residues, ζ-
cleavage at 46 and ε-cleavage at 49 residues are also thought to be mediated by 
γ-secretase. Accordingly, various AICDs (C50, C53, C57 and C59) can be 
generated during these multi-site cleavages executed by γ-secretase. However, all 
of the endogenous AICD forms are rarely  detected, probably because of their 
rapid degradation (Zhang H., 2012). 
Strong evidence suggests that the γ-secretase complex resides primarily in the 
ER, Golgi/TGN, endocytic and intermediate compartments–most of which 
(except the TGN) are not major subcellular localizations for APP
(Cupers P. et al., 2001). In addition to cleaving APP, γ-secretase cleaves a series 
of functionally important transmembrane proteins, including Notch, cadherin, 
tyrosinase, ErbB4, CD44, etc (Zhang Y. et al., 2011). 
The cleavage of various substrates appears to be dependent on the subcellular 
compartment; APP is mainly cleaved in the TGN and early endosomal domains 
whereas Notch is primarily cleaved at the plasma membrane (Tarassishin L. et 
al., 2004). Thus a disturbance in the localization of the γ-secretase complex may 
play some role in abnormal Aβ generation and AD pathogenesis (Zhang Y. et al., 
2011).
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3.2.2.The hyperphosphorilated tau hypothesis
AD belongs to a group of neurodegenerative diseases collectively designated as 
‘‘tauopathies’’, because they are characterized by the aggregation of abnormally 
phosphorylated tau protein. The mechanisms responsible for tau aggregation and 
its contribution to neurodegeneration are still unknown. Thereby, understanding 
the way of regulation of tau is of high interest in the determination of the 
possible causes of the formation of tau aggregates and to elaborate protection 
strategies to cope with these pathological lesions (Martin L. et al., 2011).
Tau protein (tubulin-associated unit) was identified in 1975 (Weingarten M.D. et 
al., 1975). Tau is a microtubule-associated protein highly conserved and 
exclusively found in higher eukaryotes.
Tau is mainly expressed in neuron and its primary role, by interacting with 
microtubules, is to stabilize neuronal cytoskeleton.
Tau protein is subdivided into four regions (fig. 17): (I) an acidic region in the 
N-terminal part; (II) a proline-rich region; (III) a region responsible for tau 
binding with microtubules that contains four repeat domains R1, R2, R3 and R4 
also called MBDs (microtubule-binding domains); and (IV) a C-terminal region.
Each repeat domain contains a conserved consensus motif KXGS, which can be 
phosphorylated at  serine (Ozer R.S. and Halpain S., 2000). Indeed, this Serine 
phosphorylation, within MBD region, decreases tau affinity  for microtubules and 
consequently  prevents its binding to microtubules which results in the 
destabilization of the neuronal cytoskeleton (Sengupta A. et al., 1998).
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Fig. 17: Schematic representation of functional domains of longest tau isoform (2N4R).
Cytoskeleton destabilization is well known to cause disruption of tau-dependent 
cellular functions including axonal growth, vesicle and organelle transport as 
well as nervous signal propagation along the nerve network formed by 
microtubules (LaPointe N.E. et al., 2009).
Phosphorylation specifically  modulates tau aggregation by disrupting its binding 
to microtubules and subsequently by promoting tau self- aggregation (Martin L. 
et al., 2011).
Various kinases and phosphatases regulate tau phosphorylation. Each tau 
phosphorylation site is subjected to the action of one or more protein kinase. Tau 
kinases are grouped into three classes: protein kinases PDPKs (proline-directed 
protein kinases), protein kinases non-PDPKs and protein kinases specific for 
tyrosines. 
Alterations in the expression and/or the activity of tau kinases such as GSK3β, 
CDK5, DYRK1A, p38 and CK1 have been reported in the brains of AD patients, 
suggesting that  one or several of them could be involved in the tau 
hyperphosphorylation (Chung S.H., 2009).
3.2.3. The Ca2+ hypothesis
A perturbed Ca2+ homeostasis has been demonstrated in AD and in particular, 
mutations in PSs have variably been correlated to alteration of Ca2+ signaling and 
different molecular targets have been identified, suggesting a physiological role 
for these proteins in intracellular Ca2+ pathway (Zampese E. et al., 2009).
PS, present as two homologous proteins PS1 and PS2, is an essential component 
of the APP cleaving enzymes γ-secretase. As an integral membrane protein, it is 
abundantly  co-expressed with markers of ER, GA, endo-exocytic vesicles and 
only a minor fraction is present at the plasma membrane level (Vetrivel K.S. et 
al., 2004).
However, both, PS1 and PS2, are regarded as a multi-faceted proteins whose 
roles can be functionally distinguished and independent of their enzymatic 
activity. In particular, several experimental evidence suggest that PSs are also 
involved in the regulation of cellular Ca2+ homeostasis (Zampese E. et al., 2009).
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Since their discovery, different FAD-lined PS mutants were reported to induce 
alterations of cellular Ca2+ handling in several cell models and in particular, it 
was observed that the FAD-mutant PS1-L286V, when expressed in PC12 cells, 
causes an increased Ca2+ release upon different stimulation (Furukawa K. et al., 
1998). Then, other two FAD mutations in PS1 (A246E and M146V) were 
described to cause larger Ca2+ release from intracellular stores and increase 
excitotoxicity  in neurons from transgenic mice expressing the mutant protein 
(Stutzmann G.E. et al., 2006). The idea that FAD-linked PS mutations are 
somehow correlated to altered Ca2+ signaling was further supported by the fact 
that these mutations could modify the sensitivity (or expression) of ER Ca2+ 
release channels (RyR and IP3R) in different  cell models, in neurons from 
transgenic AD mice as well as in isolated brain microsomes. This “Ca2+ 
overload” hypothesis is actually the only  “Ca2+ hypothesis” for AD pathogenesis, 
stating that FAD-linked PS mutations, by increasing the store Ca2+ content, cause 
excessive Ca2+ release from the ER, increase sensitization to Aβ and exocitotoxic 
stimuli and eventually lead to cell death via Ca2+-dependent mechanisms 
(Zampese E. et al., 2009).
However, different studies reported either no alteration or a reduced store Ca2+ 
content in cells expressing wt or FAD-mutant PSs. In particular, it was 
demonstrated that the FAD-linked PS2 mutations M239I and T122R reduce 
rather than increase Ca2+ release in fibroblasts from FAD patients and in cell 
lines stably  or transiently  expressing the PS2 mutants (Zatti G. et al., 2004; 
Giacomello M. et al., 2005;). In addition, an extended investigation of other 
FAD-linked PS mutants by  directly monitoring the ER and the Golgi Ca2+ content 
in different cell lines confirmed that the FAD-linked PS2 mutations cause a 
reduction in the Ca2+ level of these organelles and none of the PS1 mutations 
cause an increase (Zatti G. et al., 2006). Similar results have been obtained in rat 
cortical neurons transiently expressing FAD-mutant PSs (Zatti G. et al., 2006).
The absence of elevated ER [Ca2+] in these models suggests that the enhanced 
Ca2+ release observed by  other groups, upon expression of various FAD-linked 
PS mutants, might depend on different mechanisms, not necessarily due to an 
increased amount of Ca2+ within the stores (Zampese E. et al., 2009).
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Despite, a dysregulation of store Ca2+ handling seems the common feature of a 
heterogeneous group of FAD-linked PS mutants. 
The hypothetical mechanisms through which PS mutants exert  their effect on 
Ca2+ homeostasis are numerous. For instance, a model that was suggested in 
accordance with the Ca2+ overload supports the idea that PSs represent one of the 
molecular components of the elusive Ca2+ leak channel of the ER membrane and 
the FAD-linked PS mutants, by reducing the leak, increase the ER Ca2+ content 
(Zampese E. et  al., 2009). Moreover, in addition to the ER Ca2+ release channel 
and modulation of CCE, other mechanisms have been implicated, on the basis of 
either physical or functional interactions with proteins involved in cellular Ca2+ 
handling (Zampese E. et al., 2009), such as sorcin (Pack-Chung E. et al., 2000), 
calsenilin (Buxbaum J.D. et al., 1998), calcindin (Guo Q. et al., 1998). In 
particular, recent data by  our lab have demonstrated that PS2 mutations linked to 
FAD reduce ER and GA Ca2+ levels, in particular by inhibiting SERCA pump 
(Zatti et al., 2006 and Brunello et al., 2009). To support this idea, endogenous PS 
seems to interact with SERCA and modulate its function and the absence of both 
PSs impaire SERCA pumping activity (Green K.N. et al., 2008).
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Materials and methods
Constructs
To monitor ER Ca2+ levels, a new probe (D4ER) was created starting from the 
D1ER (Rudolf et  al. 2006) cDNA (containing the calreticulin signal sequence 
MLLPVLLLGLLGAAAD at the 5’ of CFP, and an ER retention sequence, KDEL, 
at the 3’ end of citrine) by substituting the central part of the sequence, 
containing the mutant peptide and calmodulin, with that coming from the D4cpv 
(Palmer et al. 2006), upon SphI/SacI enzymatic restriction and ligation.
To monitor cis/medial-GA Ca2+ levels, a new probe (mGo-D1cpv) was created, 
inserting the first 32 N-terminal amino acids (AA) of the resident Golgi enzyme 
β-1,6-N-acetylglucosaminyltransferase (C2gnT) (MLRTLLRRRLFSYPTKYYFM 
VLVLSLITFSVL), was introduced before the start codon of the D1cpv cDNA 
(kindly provided by Dr. R. Tsien) in the HindIII - BamHI restriction sites, after 
its isolation from the GFP fused construct kindly  provided by Dr. A. El-Battari 
(Zerfaoui et al., 2002).
To monitor trans-GA Ca2+ levels, the transGoD1cpv (tGo-D1cpv) probe was 
used. The targeting sequence of the trans-Golgi enzyme sialyl-transferase 
(MIHTNLKKKFSCCVLVFLLFAVICVWKEKKKGSYYDSFKLQTKEFQVLKSL
GKLAMGSDSQSVFSSSTQ) was introduced before the start codon of the D1cpv 
cDNA (kindly provided by  R. Tsien) in the HindIII restriction site, after its 
isolation from the Go-Aeq construct (Pinton et al., 1998).
Cell culture and transfection
SH-SY5Y cells and BHK cells were grown in DMEM containing 10% FCS, 
supplemented with L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin 
(100 µg/ml), in a humidified atmosphere containing 5% CO2.
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HL-1 cells were grown in Claycomb medium (SLD #6467; Sigma) containing 
10% FBS, norepinephrine (100 mM), L-glutamine (2 mM), penicillin (100 U/ml), 
and streptomycin (100 mg/ml).
Human fibroblasts from patients were grown in DMEM containing 20% FCS, 
supplemented with L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin 
(100 µg/ml), in a humidified atmosphere containing 5% CO2.
Cells were seeded onto glass coverslips (18 mm diameter) and transfection was 
performed at 60-70% confluence using Lipofectamine™ 2000 Transfection 
Reagent (Life Technologies) for SH-SY5Y and HL-1 cells and TransIT®-LT1 
transfection reagent (Mirus Bio LCC) for BHK cells, with 2 µg of DNA (0.5 µg 
of cameleon codifying DNAs and 1.5 µg of pcDNA3 or PSs codifying DNAs); 
fibroblasts were transfected by  electroporetion, using the Neon Transfection 
System (MPK500, Invitrogen). FRET measurements have been usually performed 
24-48 h after transfection.
SPCA1 siRNA transfection in SH-SY5Y cells and Western Blot
The day before transfection, SH-SY5Y cells were plated in order to ensure 50% 
confluence on the day of transfection. Functionally  validated siRNA directed 
against SPCA1 (CATCGAGAAGTAACATTGCCTTTA) and siGENOME RISC-
Free Control siRNA were from Thermo scientific. SPCA1 siRNAs (100 nM  each) 
or control siRNA were transfected using Lipofectamine™ 2000 Transfection 
Reagent (Life Technologies).
Proteins were resolved by SDS-PAGE, blotted onto a PVDF membrane and 
probed with selected antibodies (mouse monoclonal anti-ATP2C1, Sigma-
Aldrich); mouse monoclonal anti-β-actin (Sigma-Aldrich).
Cell imaging
Cells expressing the fluorescent  probes were analyzed using a DM6000 inverted 
microscope (Leica, Wetzlar, Germany) with a 40X oil objective (HCX Plan Apo, 
NA 1.25). Excitation light produced by a 410nm LED (Led Engin #LZ1-00UA00 
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LED) was filtered at the appropriate wavelength (425 nm) through a band pass 
filter, and the emitted light was collected through a beamsplitter (OES s.r.l., 
Padua, Italy) (emission filters HQ 480/40M (for CFP) and HQ 535/30M  (for cpv-
YFP) and a dichroic mirror 515 DCXR). The beamsplitter permits the collection 
of the two emitted wavelengths at the same time, thus preventing any artefact 
due to movement of the organelles. All filters and dichroics were from Chroma 
Technologies (Bellow Falls, VT, USA). Images were acquired using an IM  1.4C 
cool camera (Jenoptik Optical Systems) attached to a 12-bit frame grabber. 
Synchronization of the excitation source and cool camera was performed through 
a control unit ran by a custom-made software package, Roboscope (developed by 
Catalin Cubotaru at VIMM, Padua, Italy); this software was also used for image 
analysis. Exposure time and frequency of image capture varied from 200 ms to 
400 ms, depending on the intensity  of the fluorescent signal of the cells analyzed 
and on the speed of fluorescence changes.
Cells were mounted into an open-topped chamber and maintained in an 
extracellular medium (modified Krebs-Ringer Buffer, mKRB; in mM: 135 NaCl, 
5 KCl, 1 MgCl2, 0.4 KH2PO4, 1 MgSO4, 20 HEPES, 11 glucose, pH 7.4). 
Classical experiments started in 1 mM  CaCl2; after perfusion with 300 µM 
EGTA, cells were stimulated by perfusion of bradykinin (BK, 100 nM) and/or 
CPA (20 µM); thereafter, the Ca2+ ionophore ionomycin (1 µM) was applied (not 
with the ERD4 probe) to completely  discharge the stores; finally digitonin (40 
µM, to obtain plasma membrane permeabilization) in Ca2+-free intracellular-like 
medium [130 mM KCl, 10 mM NaCl, 1 mM MgCl2, 2 mM  succinic acid and 20 
mM Hepes, 7,05 pH, at 37°C] and then a saturating CaCl2 concentration (3 mM) 
were applied, in order to verify the dynamic range of the probe.
For Ca2+ pumping experiments a Ca2+-buffer solution was prepared by  adding to 
the intracellular medium: 1 mM H-EDTA, 1 mM MgCl2, 2 mM EGTA and 350 
µM  CaCl2. 100 µM  ATP-Na was added fresh to this Ca2+-buffered solution. The 
free [Ca2+] (100 nM) was estimated by MaxChelato r2.5 and checked by 
fluorimetric measurements with fura-2. 
All media were perfused through a temperature controller (Warner Instruments, 
TC-324B) set to have a constant temperature of 37°C in the chamber.
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Immunocytochemistry
Cells decorated with anti-GM130 (BD Bioscience Pharmigen, San Jose CA, 
USA), anti-TGN46, anti-Giantin (AbCam, Cambridge UK), anti-calreticulin 
(Pierce #PA3-900) and anti-PS2 (Santa Cruz Biotechnology, Dallas Texas, USA) 
antibodies were fixed in Phosphate Buffered Saline (PBS) containing 4% 
paraformaldehyde for 15 min, incubated with 50 mM  NH4Cl for 20 min, 
permeabilized with 0.1% Triton X-100 in PBS 3 min and then blocked with 2% 
BSA and 0.2% gelatine for 30 min; anti-GM130 (1:1000), anti-Giantin (1:300) 
and anti-calreticulin (1:100) were added for 1 hour at room temperature, anti-
TGN46 (1:200) and anti-PS2 (1:500) were added for 2h at 37°C. Samples were 
treated with Alexa Fluor 488 (555, 568 or 647) conjugated goat anti-mouse, anti-
rabbit or rabbit anti-goat IgG (Molecular Probes Invitrogen, Eugene OR) for 1 
hour at room temperature and mounted with Mowiol (Sigma-Aldrich Saint Louis, 
MI). Images were collected at Leica TCS-SP5-II confocal system, equipped with 
a PlanApo 100×/1.4 numerical aperture objective. For all images, pinhole was set 
to 1 Airy unit. The Argon laser line (488 nm) was used to excite the Cameleon 
sensors or AlexaFluor488 the He/Ne 543 nm laser was used to excite the 
AlexaFluor555/568 and the AlexaFluor647 was excited by the HeNe 633nm laser 
line. Video microscopy was performed at 1024×1024 pixels per image, with a 
100Hz acquisition rate. Images were elaborated with ImageJ program (Wayne 
Rasband, Bethesda,USA). Z-stacks were acquired with a step of 0.42 µm.
Materials
Restriction and modification enzymes were purchase from NEB Inc. (Ipswich, 
MA). CPA, digitonin (Dig), BK, ATP-Na, thapsigargin, bis-phenol and caffeine 
were purchased from SIGMA-Aldrich; ionomycin (Iono) from Calbiochem and 
NAADP from Tocris. All other materials were analytical or highest available 
grade.
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Statistical analysis
Off-line analysis of FRET experiments was performed with ImageJ software 
(Wayne Rasband, Bethesda, USA). Cpv-YFP, citrine-YFP and CFP images were 
subtracted of background signals and distinctly analyzed after selecting proper 
regions of interest (ROIs) on each cell; subsequently, a ratio between cpv-YFP 
(or citrine-YFP) and CFP emissions was calculated (R=F530/F480). Data are 
presented as a normalized ΔR/R0 %, where R0 is the R value at the beginning of 
the experiment (t0) and ΔR is the R value at  each time (t) of the experiment 
minus R0, or as % of minimum and maximum FRET.
All the data are representative of at least five different experiments. Data were 
analyzed by Origin 7.5 SR5 (OriginLab Corporation). Averages are expressed as 
mean ± s.e.m. (n = number of independent experiments; ∗ = p  < 0.05, ∗∗ = p < 
0.01, ∗∗∗ = p < 0.001, unpaired Student’s t test).
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Results
1. Ca2+ handling among within the medial-Golgi
In order to study in details, and at  the single cells level, the effects of FAD-
mutants PSs on intracellular Ca2+ handling, we firstly characterized the cis/
medial-Golgi sub-compartement using a new created Cameleon Ca2+ probe 
specifically targeted to this intracellular sub-organelle.
1.1. A new cameleon probe specifically targeted to the medial-
Golgi
In order to specifically evaluate the [Ca2+] in the medial part of the GA, in our 
lab a new cameleon Ca2+ probe was generated, taking advantage of the first 32 
N - t e r m i n a l A A o f t h e r e s i d e n t G o l g i e n z y m e β - 1 , 6 - N -
acetylglucosaminyltransferase (C2gnT), which have been shown to represent the 
minimal cis/medial-Golgi targeting determinant when fused to a GFP (Zerfaoui 
et al., 2002). This sequence was inserted at the 5’ of the cDNA coding for the 
cameleon D1cpv (Fig. 18 A).
Fig. 18: (A) The first 32 AA of the Golgi enzyme β-1,6-N-acetylglucosaminyltransferase (C32), 
 were cloned upstream of the cDNA coding for the cameleon D1cpv. (B) Z-projection 
 confocal image (10 sections) of a SH-SY5Y cell expressing the new mGoD1cpv 
 excited at 488 nm. Scale bar, 10 µm.
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As shown in figure 18B, when the human neuroblastoma cell line SH-SY5Y was 
transiently  transfected with the cDNA for the new Golgi cameleon, our probe 
localized in cisternae-like structures and small vesicles localized in the 
perinuclear region, thus appearing as a Golgi complex like structure.
Figure 19 shows the new Golgi probe expressed in SH-SY5Y cells (Fig. 19 A, D 
and G) that were fixed and immuno-labelled with antibodies against bona fide 
markers for cis- (GM130, Fig. 20 B), cis/medial- (Giantin, Fig. 19 E) and trans- 
(TGN46, Fig. 19H) Golgi compartments. There is a good overlap of the probe 
fluorescence with that of the cis/medial-Golgi marker Giantin (Fig. 19 F), while 
a partial separation was observed towards the signals of GM130 (Fig. 19C) and 
TGN46 (Fig. 19I).
Statistical analysis (by ImageJ) of confocal Z-stacks of cells marked as above, to 
quantify the signal of co-localizations of the new probe against the three markers 
(Fig. 20A), reveals a Pearson’s coefficient  (an index of co-localization that 
varies from -1, no co-localization, to +1, complete overlapping; Adler J. and 
Parmryd I., 2010) demonstrating a partial overlap  of our probe versus the three 
endogenous markers, but with higher value for Giantin (cis/medial-Golgi) and 
TGN46 (trans-Golgi), compared to that for GM130 (cis-Golgi).
The spatial resolution of confocal microscopy is about 0.4 µm on the X/Y axis, 
but only 1 µm, at the best, on the Z axis. Given that  the diameter of the GA 
cisternae can be significantly smaller than these values, the question is whether 
the co-localization of the new probe with the different markers is real or only 
apparent. 
Indeed, when we calculated the Pearson’s coefficient for the three endogenous 
Golgi marker proteins (GM130, Giantin, TGN46), one to each other, a high co-
localization index between the cis/medial- and the trans-GA marker was found, 
while the signals coming from the cis- and the trans-compartment of the GA (and 
from the cis- and the medial-) appeared better separated (Fig. 20 B), although it 
is known that they are localized in distinct GA sub-compartments.
A further co-localization analysis was carried out to investigate more precisely 
the localization of the new probe within the GA: SH-SY5Y cells were treated 
with the microtubule depolymerizing agent nocodazole, which induces the 
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Fig. 19: Confocal fluorescence images of the Golgi Ca2+ probe express SH-SY5Y cells either 
 excited at 488 nm (A, D and G) or decorated with antibodies against the cis-Golgi 
 marker GM130 (B), the medial-Golgi marker Giantin (E) and the trans-Golgi marker 
 TGN46 (H), and excited at 543 nm. Merging of the two upper images (C, F and I). 
 Insets in each panel show magnifications of selected cisternae. Scale bar, 10 µm.
accumulation of dispersed individual Golgi stacks in the cytoplasm, improving 
the recognition of different GA sub-compartments (Thyberg J and Moskalewski 
S., 1999). In figure 21A, SH-SY5Y cells treated with nocodazole, fixed and then 
triple immuno-labelled for GM130, Giantin and TGN46, were analyzed as above. 
In this case, the co-localization of the three endogenous markers appears more 
distinct and, particularly, when the vesicles were image en face, a typical 3 
colour staining was often evident, with the Giantin signal closer and partially 
overlapped to that of TGN46, while the GM130 signal was more clearly 
separated from the other two. 
Similarly, cells expressing the probe were treated, fixed and immuno-labelled, 
with the same two antibodies towards the cis- and the trans-GA marker (Fig. 21 
B). In several structures, the spatial separation among the three signals was 
striking evident. On the contrary, if the same protocol was applied, but the cells 
were immuno-labelled with antibodies against GM130 and Giantin (Fig. 21 C), 
the probe signal appears almost completely  separated from the first  marker, but 
completely largely overlapped with the second.
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Fig. 20: Pearson’s coefficients for signal co-localization between (A) the new probe and the 
 three Golgi markers GM130, Giantin and TGN46, or (B) between the three markers for 
 different Golgi compartments. The values were calculated from Z-axis confocal stacks 
 by the Image-J JACoP plug-in; mean ± SEM; n (number of cells) ≥ 10.
In conclusion, the new probe appears to be almost completely excluded from the 
cis-Golgi compartments, while it well overlapped with vesicles marked with 
Giantin (cis/medial-Golgi). A partial overlapping between the probe distribution 
and TGN46 (trans-Golgi) was observed, similar to that between the trans-GA 
marker and Giantin. Accordingly, for simplicity, the new probe from now on is 
named medialGo-D1cpv (mGo-D1cpv).
Fig. 21: Confocal fluorescence images corresponding to cells treated with nocodazole and 
 expressing the mGo-D1cpv (and excited at 488 nm; B and C, blue). Cells were 
 decorated with antibody against the cis-Golgi marker GM130 (and excited at 647 nm; 
 A, B, C, green), the medial-Golgi marker Giantin (and excited at 488 nm; A, blue; or 
 at 543 nm; C, red) and the trans-Golgi marker TGN46 (and excited at 543 nm; A and 
 B,  red).  Insets in each panel show magnifications of en face vesicles. Bar, 10 µm.
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1.2. Calibration of the new mGo-D1cpv
I In order to determine the absolute value of [Ca2+] within the medial-GA, the in 
situ calibration of the new probe was carried out, performing passive Ca2+ 
loading experiments permeabilizing cells with digitonin in an intracellular-like 
medium containing different Ca2+ concentrations and no energy source (Fig. 22 
A and B).
The experimentally calculated Kd for the new probe is 27.4 µM  (Fig. 22, panel 
C) and the mean Ca2+ level that matched the cpv-YFP/CFP fluorescence emission 
ratio of mGo-D1cpv expressing SH-SY5Y cells at rest before permeabilization 
was 235 ± 30 µM (mean ± s.e.m., n = 24 for every point).
Fig. 22: Representative kinetics of FRET changes (% of max) in permeabilized SH-SY5Y 
  cells transiently expressing the mGo D1cpv (A-B). Where indicated,  digitonin- 
  permeabilized cells were bathed with an intracellular-like medium without energy 
  source and containing different [Ca2+]; 3mM CaCl2 was finally added to reach the 
  maximum value. (C) In situ calibration curve for the mGo D1cpv, obtained perfusing 
  the cells with different [Ca2+]-containing intracellular-like medium as described in A. 
  Mean ± s.e.m., n ≥ 3 for each Ca2+ concentration.
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1.3 Ca2+ handling in the medial-Golgi
Functional experiments were carried out in SH-SY5Y cells transiently 
transfected with the cDNA encoding mGo-D1cpv. Cameleon-probes are FRET-
based indicators and FRET occurs between the two GFP mutants (the CFP and 
the cpv-YFP). This phenomenon is caused by  the interaction between Ca2+, 
Calmodulin (CaM) and its target peptide M13. Variations in [Ca2+] can be 
followed as variations in the ratio between cpv-YFP and CFP fluorescence 
emission. Changes in [Ca2+] can be conveniently expressed as ΔR/R0 or R% of 
the maximal fluorescence obtained upon normalization by the minmum (Ca2+ free 
medium) and maximum (3 mM [Ca2+]) FRET. A drop  in the ΔR/R0 value 
indicates a decrease in [Ca2+] within the organelle.
Figure 23 shows typical ΔR/R0 changes in mGo-D1cpv expressing SH-SY5Y 
cells after addition of different stimuli. The perfusion in a Ca2+-free EGTA-
containing (300 µM) medium of an IP3-generating stimulus, such as bradikinin 
(BK; Fig. 23 B), results typically  in small ΔR/R0 decreases (a drop of 10 ± 0.4%, 
mean ± s.e.m., n = 14; Fig. 32 E) within the GA region. The following addition 
of the Ca2+ ionophore ionomycin causes a rapid and large decrease in terms of 
ΔR/R0 (a drop  of 70 ± 2.1%, mean ± s.e.m., n = 37; Fig. 23 E) within the medial-
Golgi, down to a level that was not significantly  affected by  the subsequent 
permeabilization of the plasma membrane with digitonin.
We then tested the effect on medial-Golgi Ca2+ handling of the SERCA inhibitor 
cyclopiazonic acid (CPA), added alone (Fig. 23 C) or in combination with BK 
(Fig. 23 D): the SERCA inhibitor alone resulted in a slow decrease of ΔR/R0 
down to a new steady  state value approximately halfway between the value at 
resting condition and the minimum obtained after cell permeabilization with 
digitonin in Ca2+-free, EGTA-containing medium (-40 ± 3.4%, mean ± s.e.m., n = 
21; Fig. 23 E); however, when the addition of the SERCA inhibitor was rapidly 
followed by BK, the slow CPA-induced ΔR/R0 decrease was strongly accelerated 
(Fig. 23 D) until a new steady-state value, similar to that reached upon CPA 
addition alone, was reached (-40 ± 1%, mean ± s.e.m., n = 9; Fig. 23 E). 
Addition of ionomycin, after CPA, induced, in both cases, a further large drop  in 
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the ΔR/R0 signal (Fig. 23 C and D). In Figure 23 E, the averaged decreases in 
ΔR/R0 values obtained in SH-SY5Y cells expressing the mGo-D1cpv upon 
different stimulations are reported.
The partial depletion of the medial-Golgi by  SERCA inhibitors suggests that this 
Golgi compartment is endowed with additional mechanisms for its Ca2+ uptake, 
one of which sensitive to the drugs. The existence in the medial-Golgi of a Ca2+ 
uptake mechanism other than the SERCA was then investigated. First, cells 
expressing the mGo-D1cpv were treated (in a Ca2+ free, EGTA-containing 
medium) with ionomycin to completely  deplete Ca2+ from the lumen; ionomycin 
was then washed away, cells were treated with the irreversible SERCA inhibitor 
thapsigargin (Tg, 1 µM) and finally 1mM CaCl2 was added to the medium. For 
comparison, the same procedure was employed in parallel cells expressing an ER 
targeted cameleon Ca2+ probe, the ER-D4.
Fig. 23: Image of a SH-SY5Y cell expressing the mGo-D1cpv probe.  Bar, 10 µm (A). 
 Representative ΔR/R0 variations in medialGo-D1cpv expressing SH-SY5Y cells in 
 response to different stimuli. Where indicated 1 mM CaCl2,  300 µM EGTA, 100 nM 
 bradikinin (BK), 20 µM cyclopiazonic acid (CPA), 1 µM ionomycin (Iono), 50 µM 
 digitonin (Dig) were perfused (B-C-D). Statistical medial-Golgi ΔR/R0 reduction in 
 SH-SY5Y cells upon different stimulation (mean ± s.e.m.; n ≥ 9) (E).
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Figure 24 A shows that, while a substantial re-uptake of Ca2+ was observed in 
these conditions in the medial-Golgi (black trace), no Ca2+ refilling was observed 
in cells expressing the ER Ca2+ sensor (grey  trace). Similar results were obtained 
when refilling of pre-emptied stores was followed in cells permeabilized with 
digitonin and perfused with an intracellular-like medium at fixed [Ca2+] (Fig. 24 
B).
Fig. 24: Representative medial-GA (black trace) and ER (grey trace) Ca2+ refilling kinetics in 
 pre-emptied intact SH-SY5Y cells treated with thapsigargin (1 µM) (A). Where 
 indicated, Ca2+-free, EGTA (300 µM)-containing medium was changed with the mKRB 
 containing 1mM CaCl2.   Representative medial-GA (black trace) and ER (grey trace) 
 Ca2+ refilling kinetics in pre-emptied, digitonin-permeabilized SH-SY5Y cells treated 
 with thapsigargin (1 µM) (B).  Where indicated, intracellular-like medium containing 
 EGTA (300 µM) was changed with an intracellular-like medium at 0.1 µM [Ca2+].
We thus hypothesized that the medial-Golgi is equipped by both the SERCA and 
the SPCA-1 pump, known to be present in the trans-GA. To further investigate 
this Ca2+ uptake mechanism in the medial-Golgi, we verified in SH-SY5Y cells 
expressing the medial-Golgi probe the effect of SPCA1 knock-down by RNA 
interference (Fig. 25). SH-SY5Y cells treated with specific siRNA against 
SPCA1 and expressing the mGo-D1cpv were analyzed by Western blotting with 
an anti-SPCA1 antibody: a reduction in the total SPCA1 protein level of 54 ± 9% 
(n=3) was revealed in interfered cells, compared to control scramble siRNA-
transfected cells (Fig. 25A). Taken into consideration the transfection efficiency 
in these cells (~70%), this should correspond to a reduction of about 70% of 
SPCA1 level in the transfected cells.
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Fig. 25: Western blot of control (Ctrl, scrambe siRNA-trasfected) and interfered (siSPCA1- 
  transfected) SH-SY5Y cell extracts visualized with anti-SPCA1 and anti-actin 
  antibodies (A). A significant reduction in the level of SPCA1 was observed in 
   interfered cells (-54 ± 9%, mean ± s.e.m., n = 3).
  Representative FRET changes (% of max) in mGo-D1cpv expressing control (black 
  trace) and interfered (grey trace) SH-SY5Y cells in response to the addition of 
  different stimuli (B). Where indicated, CaCl2 1 mM, EGTA 300 µM, CPA 20 µM, Iono 
  1 µM were perfused. Statistical medial-Golgi FRET variations in SH-SY5Y cells 
   treated as in B (C).
The effects of SPCA1 down-regulation were then tested on medial-GA Ca2+ 
handling. Figure 25 B showed that SPCA1 knockdown caused a reduction in the 
FRET value in resting condition and no further effect upon CPA addition, 
compared to controls (Fig. 25 C); accordingly, the additional drop  induced by 
ionomycin was larger in controls compared to SPCA1 knocked-down cells (Fig. 
25 C).   
The question that arises as to whether the medial-Golgi is endowed with other 
Ca2+-releasing channels than the IP3R.
To investigate the expression of TPCs, SH-SY5Y cells transiently expressing 
mGo-D1cpv were permeabilized with digitonin in an intracellular-like medium 
and stimulated with nicotinic acid adenine dinucleotide phosphate (NAADP), a 
potent Ca2+-releasing second messenger that should specifically  activate TPCs 
(Calcraft et  al., 2009). The addition of NAADP (from 10 up to 100 nM) had no 
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appreciable effect on DR/R0 (data not shown), indicated that the TPCs-mediated 
Ca2+-releasing mechanism is not present in the medial-Golgi.
To investigate the presence of the RyRs in the medial-GA we expressed the 
mGolgi-D1cpv in a stable cardiac cell line, HL-1 (Figure 26 A), which shows 
high levels of RyRs, type 2 expression (George et al., 2003). Figure 26 B shows 
that the addition of depolarizing concentrations of KCl (30 mM) induced a clear 
drop in ΔR/R0 (27% ± 0.8%; n = 8); similarly, the addition of caffeine (Caff, 20 
mM), either after KCl (Figure 26 B) or alone (Figure 26 C), caused a rapid drop 
in ΔR/R0 (-12% ± 1.3% and -10% ± 1.4%, respectively; n = 8).
Fig. 26: Ca2+ response by medial-GA in HL-1 cells upon RyRs stimulation. Image of an HL-1 
  cell expressing the mGo-D1cpv probe (selected ROI).  Bar, 10 µm (A).  Representative 
  ΔR/R0 changes of mGo-D1cpv in HL-1 cells in response to different stimuli. Where 
  indicated, 1 mM CaCl2, 50 mM KCl,  20 mM Caff, 300 µM EGTA, 1 µM Iono, and 50 
  µM Dig were added through the perfusion system (B). Representative ΔR/R0 changes 
  in medial-Golgi (black trace) and trans-Golgi (grey trace) of HL-1 cells in response to 
  different stimuli. Where indicated, 1 mM CaCl2, 20 mM caffeine (Caff), 20 µM CPA, 
  300 µM EGTA, 1 µM Iono, and 50 mM Dig were added through the perfusion system.
Pag. 54
Thus, the medial-Golgi sub-compartment seems to be equipped with IP3Rs and 
RyRs and its Ca2+ uptake can be mediated by both SERCA and SPCA1 pumps.
2. A new Cameleon probe specifically targeted to ER
In order to specifically evaluate the [Ca2+] within the ER at the single-cell level, 
we generated a new cameleon Ca2+ probe, starting from the ER-D1 cDNA 
present in the lab (Rudolf et al. 2006), which contains the calreticulin targeting 
sequence (MLLPVLLLGLLGAAAD) at the 5’ of the CFP, and an ER retention 
sequence (KDEL) at the 3’ end of YFP (Fig. 27 A). The central part of the ER-D1 
sequence (D1), containing calmodulin and the mutant peptide M13, was 
substituted with that  coming from the D4cpv (Palmer et al. 2006), upon SphI/
SacI enzymatic restriction and following ligation. This strategy was utilized to 
improve the small dynamic range and low Kd of the original ERD1 probe. The 
new probe was named ER-D4.
As shown in figure 27 B, in BHK cells transiently transfected with the cDNA for 
ER-D4 (in green) and immuno-labelled with a bona fide marker for the ER 
(calreticulin, in red), our probe localized in a reticular structure present in all the 
the cell that perfectly overlaps with the calreticulin signal.
Fig. 27: (A) Design of the new construct codifying the ER-D4. (B) Confocal fluorescence 
 images of a ER-D4 expressing BHK cell excited at 488 nm (in green) and decorated 
 with antibodies against calreticulin (excited at 555 nm; in red). Bar, 10 µm.
A B
Pag. 55
2.1. Calibration of the new ERD4
To define the [Ca2+] within the ER compartment, the in situ calibration of the 
new probe was performed by passive Ca2+ loading experiments, permeabilizing 
the cells with digitonin in an intracellular-like medium, containing different Ca2+ 
concentrations and no energy source (Fig. 28 A).The calculated apparent Kd for 
the new probe is 305 µM  (Fig.28 B) and the mean Ca2+ level that matched the 
YFP/CFP fluorescence emission ratio in SH-SY5Y cells at rest before 
permeabilization was 475 ± 50 µM (mean ± s.e.m.,  n = 47).
Fig. 28: (A) Representative kinetics of FRET changes (% of max) in permeabilized SH-SY5Y 
 cells transiently transfected with ER-D4. Where indicated, digitonin-permeabilized 
 cells were bathed with an intracellular-like medium without energy source and 
 containing different [Ca2+]. (B) In situ calibration curve for the ER-D4, obtained 
 perfusing the cells with different [Ca2+]-containing intracellular-like medium as 
 described in A. Mean ± s.e.m., n ≥ 27 for each Ca2+ concentration. 
A
B
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3. Effects of familial Alzheimer’s disease linked-
    Presenilin (PS) mutants on intracellular Ca2+ 
    stores homeostasis
To study in details the effects of FAD-linked PS mutations in  ER and medial- 
and trans-GA sub-compartments, we transfected the SH-SY5Y human 
neuroblastoma cell line with the cDNA coding for the ER-D4, the tGo-D1cpv or 
the mGo-D1cpv cameleon probes and those for different FAD-PS mutated form, 
PSs wt or the void vector, as control. Upon different protocols, Ca2+ 
measurements were performed.
3.1 Intracellular localization of PS2 in SH-SY5Y cells
In order to study the effect of transient over-expression of PSs in SH-SY5Y cells, 
we firstly  checked whether they co-localized intracellularly  with the three 
cameleon probes used for Ca2+ measurements.
Cells over-expressing PS2 (wt or T122R) and the probes were immuno-labelled 
with an antibody  against  PS2 (Fig. 29) and observed at the confocal microscope. 
A good co-localization between the signal coming from the three fluorescent 
probes and that from the antibodies was found in both conditions, thus 
suggesting that  PS2, both mutated and wt, is expressed at the level of the ER, the 
medial- and the trans-GA.
3.2 FAD-linked-PS2 strongly affect the Ca2+ level of the ER and 
 medial-GA but do not affect the Ca2+ level of the trans-GA
In order to study the effect of FAD-linked PSs on Ca2+ handling of intracellular 
stores, Ca2+ measurements were performed in SH-SY5Y cells transiently 
transfected with the cDNAs coding for ER-D4, mGo-D1cpv or tGo-D1cpv and 
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different PS1 or PS2 (wt or FAD- PS1-A246E and FAD-PS2-T122R), or the void 
vector, as control.
Fig. 29: Confocal fluorescence images corresponding to SH-SY5Y cells expressing the three 
 Ca2+ probes excited at 488 nm (A, D, G, J, M and P) or decorated with antibody 
 against PS2 (B, E, H, K, N and Q) and excited at 543 nm. Merging of the two 
 previous images (C, F, I, L, O and R): the yellow colour indicates overlapping of the 
 green and red signals. Insets show magnifications of selected ROIs. Bar, 10 µm.
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The Ca2+ content at rest was firsly  observed (Fig. 30 and 31), founding that the 
over-expression of PS2 wt or T122R, but not of PS1 wt or A246E, affects ER the 
Ca2+ level of the ER and that of the medial-GA, being strongly  reduced compared 
to control cells.
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Within the ER, a major effect  was observed upon of PS2-T122R over-expression: 
in terms of FRET value (% of the max; Fig. 30 B), a  reduction, from about  62 ± 
1.7 % (mean ± s.e.m., n = 23), in control cells, to about 46 ± 2,8 % (mean ± 
s.e.m., n = 14), in cells over-expressing PS2-T122R was observed; in terms of 
[Ca2+] (Fig. 30C), this represents a reduction from about 475 ± 50 µM (mean ± 
s.e.m., n = 23) in controls to about 255 ± 40 µM (mean ± s.e.m., n = 14) in PS2-
T122R expressing cells. The effect was mimicked by the over-expression of 
PS2wt, that reduces ER Ca2+ content to 286 ± 30 µM (mean ± s.e.m., n = 13), but 
not by the over-expression of PS1, either wt or A246E (Fig. 30 A and B).
A B
Fig. 30: Representative traces of SH-SY5Y cells co-expressing the ER-D4 probe and either 
 PS2-T122R, PS2wt,  PS1-A246E or PS1wt (A) in response to different stimuli.  (B) 
 Averaged ER FRET and [Ca2+] values in resting cells expressing PS2-T122R, PS2wt, 
 PS1-A246E or PS1wt (mean ± s.e.m.; n ≥ 11).
Similar results were obtained with the medial-Golgi probe: PS2-T122R over-
expression leads to a reduced FRET value at rest, from about 82 ± 1.5 % (mean ± 
s.e.m., n = 24), in control cells, to about 58 ± 3 % (mean ± s.e.m., n = 15), in 
cells over-expressing the mutated protein; this represents, a reduction in [Ca2+] 
within the organelle at rest (Fig. 31 B) from about 235 ± 30 µM (mean ± s.e.m., 
n = 24) in controls to about 62 ± 6 µM (mean ± s.e.m., n = 15) in over-
expressing cells. As for the ER, a similar effect was observed upon over-
expression of PS2wt, that reduces ER Ca2+ content to 52 ± 7 µM  (mean ± s.e.m., 
n = 10), but not upon over-expression of PS1, either wt or A246E (Fig. 31 A and 
B). 
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No differences in Ca2+ content has been found in trans-GA between control cells 
and those expressing wt or mutated PS1 or PS2: [Ca2+] within this sub-organelle 
in resting condition was about 146 ± 15 µM (mean ± s.e.m., n = 16) for controls, 
156 ± 19 µM  (mean ± s.e.m., n = 15) for PS2-T122R over-expressing cells, 157 ± 
14 µM (mean ± s.e.m., n = 17) for PS2wt over-expressing cells, 173 ± 15 µM 
(mean ± s.e.m., n = 12) for PS1-A246E over-expressing cells and 167 ± 17 µM 
(mean ± s.e.m., n = 12) for PS1wt over-expressing cells  (Fig. 31 C and D).
Fig. 31: Representative FRET  variations of mGo-D1cpv (A) or tGo-D1cpv (C) in PS2-T122R, 
 PS2wt, PS1-A246E or PS1wt expressing SH-SY5Y cells in response to different 
 stimuli. Averaged medial-Golgi (B) and trans-Golgi (D) FRET and [Ca2+] values in 
 resting cells expressing PS2-T122R, PS2wt, PS1-A246E or PS1wt (mean ± s.e.m.; n ≥ 
 10).
A B
C D
To verify that the observed PS effects were not due to the over-expression 
procedure, human fibroblasts from different FAD patients (as well as from 
healthy age-matched controls) were similarly analysed. In fibroblasts from a 
FAD patient carrying the PS2-N141I mutation a reduced [Ca2+] was measured 
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within the ER (Fig. 32) compared to human control fibroblasts from three 
different individuals (PS2 ctrl 1-3). In terms of FRET changes, a reduction from 
values of about 75 ± 1%, 72 ± 3 % and 70 ± 3 % (mean ± s.e.m., n ≥ 14), 
measured in the three controls, to about 60 ± 2 % (mean ± s.e.m., n = 19) in PS2-
N141I fibroblasts was observed. In terms of Ca2+ this means that while control 
fibroblasts showed an ER [Ca2+] around 775 ± 50 µM(850 ± 60 µM, 760 ± 80 µM 
and 695 ± 20 µM, respectively;  mean ± s.e.m., n ≥ 14), PS2-N141I fibroblasts 
showed an ER [Ca2+] of 450 ± 40 µM (mean ± s.e.m., n = 22). 
On the contrary, there were no difference in FRET (73 ± 3 % (mean ± s.e.m., n = 
14) and 75 ± 2 % (mean ± s.e.m., n = 16), respectively) and [Ca2+] (840 ± 80 µM 
(mean ± s.e.m., n = 14) and 790 ± 70 µM (mean ± s.e.m., n = 16), respectively 
(Fig. 32 B); resting values between controls and PS1-A246E human fibroblasts.
Fig. 32: Representative FRET variations of ER-D4 (A) in FAD PS2-N141I,  PS1-A246E human 
 fibroblasts and their controls,  in response to different stimuli. (B) Averaged ER FRET 
 and [Ca2+] values in resting control, PS2-N141I and PS1-A246E fibroblasts (mean ±  
 s.e.m.; n ≥ 14).
BA
As for the ER, PS2-N141I human fibroblasts showed a reduced [Ca2+] in the 
medial-GA (Fig. 33 A and B) compared to control cells (PS2 Ctrl 1). In terms of 
FRET values, a reduction from 87 ± 1 % (mean ± s.e.m., n = 10) in control 
fibroblasts, to 69 ± 3 % (mean ± s.e.m., n = 10) in PS2-N141I fibroblasts was 
observed, corresponding to a medial-Go [Ca2+] of 297 ± 30 µM, (mean ± s.e.m., 
n = 10) in controls and of 84 ± 13 µM (mean ± s.e.m., n = 10) in PS2-N141I 
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fibroblasts. There were instead no difference in FRET and Ca2+ values between 
controls and PS1-A246E fibroblasts (Fig. 33 C and D; FRET  values of 78 ± 2 % 
(mean ± s.e.m., n = 10) and 79 ± 2 % (mean ± s.e.m., n = 10); [Ca2+] of 123 ± 5 
µM   (mean ± s.e.m., n = 10) and 127 ± 9 µM  (mean ± s.e.m., n = 10); for control 
and PS1-A246E fibroblasts, respectively) .
No differences in Ca2+ content has been found in trans-GA between PS2-N141I 
or PS1-A246E compared to their respective controls (Fig. 33, panels F, G, H): 
control and PS2-N141I fibroblasts showed respectively a trans-Golgi Ca2+ 
content at the steady state of 105 ± 7 µM  (mean ± s.e.m., n = 10) and 110 ± 12 
µM (mean ± s.e.m., n = 10).
Fig. 33: Representative FRET variations of mGo-D1cpv (A) or tGo-D1cpv (C) in FAD 
 PS2-N141I  and PS1-A246E fibroblasts (and corresponding controls), in response to 
 different stimuli. (B and D) Averaged FRET and [Ca2+] values of medial-GA and 
 trans-GA in PS2-N141I and PS1-A246E FAD fibroblasts, and corresponding controls,  
 at rest controls, (mean ±  s.e.m.; n ≥ 10).
A
C D
B
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3.3 FAD-linked-PS2 mutants reduce ER and medial-Golgi Ca2+ 
 uptake by inhibiting SERCA activity
In order to investigate how PS2 affects Ca2+ homeostasis within the ER and the 
medial-Golgi, we performed some experiments in permeabilized SH-SY5Y cells 
transiently  transfected either with the ER-D4 or the mGo-D1cpv probe and with 
PS2 wt or T122R, or the void vector as control.
Cells were pre-incubated in a Ca2+-free EGTA-containing (300 µM) medium and 
the SERCA inhibitor CPA (20 µM) for 10 minutes, to induce intracellular Ca2+ 
stores depletion. Cells were permeabilized in an intracellular-like medium 
containing EGTA (300 µM) and digitonin (40 µM) for 30 seconds. They were 
then washed with an intracellular-like medium containing only EGTA (300 µM) 
and perfused with an intracellular-like medium containing 100 nM Ca2+ in the 
presence of ATP (200 µM; Fig. 34 and 35).
Within the ER, in SH-SY5Y cells, the expression of PS2-T122R, or its wt form, 
significantly reduced the plateau reached upon Ca2+ addition, as well as the Ca2+ 
uptake rate (Fig. 34 A). Indeed, the plateau reached after Ca2+ refilling(Fig. 34 
B) was of 486 ± 20 µM  (mean ± s.e.m., n = 11) in control cells, 364 ± 15 µM 
(mean ± s.e.m., n = 10) in cells over-expressing PS2 wt and 350 ± 40 µM (mean 
± s.e.m., n = 12) in cells over-expressing PS2-T122R; the initial Ca2+ uptake rate 
(calculated as the maximal values of the first derivate of momentaneous [Ca2+]) 
was of 5.93 ± 0.62 µmol Ca2+/s (mean ± s.e.m., n = 11) in control cells, 3.70 ± 
0.63 µmol Ca2+/s (mean ± s.e.m., n = 10) in cells over-expressing PS2 wt and 
4.14 ± 0.40 µmol Ca2+/s (mean ± s.e.m., n = 12) in cells over-expressing PS2-
T122R. 
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Fig. 34: Representative ER-D4 (A) FRET changes in PS2-T122R or PS2wt expressing 
 SH-SY5Y cells, in response to different stimuli. (B) Averaged FRET and [Ca2+] 
 values reached in the ER upon Ca2+ refilling and (C) averaged [Ca2+]/s values for the 
 first 10 s of Ca2+ uptake in control,  PS2-T122R and PS2wt expressing SH-SY5Y cells 
 (mean ± s.e.m.; n ≥ 10).
A
C
B
Similarly, in the medial-GA, the expression of PS2-T122R significantly reduced 
both the refilling reached plateau and the initial Ca2+ uptake rate (fig. 34 A, B; a 
reached plateau values of 148 ± 20 µM  (mean ± s.e.m., n = 13) and of 35 ± 6 µM 
(mean ± s.e.m., n = 15); an initial Ca2+ uptake rate of 1.64 ± 0.35 µmol Ca2+/s 
(mean ± s.e.m., n = 13) and 0.63 ± 0.06 µmol Ca2+/s (mean ± s.e.m., n = 15) in 
controls and PS2-T122R expressing cells, respectively.
Medial-Golgi Ca2+ uptake were affected also upon over-expression of wt PS2, 
although its effect was weaker than that induced by the FAD-mutant (Fig. 35), 
with a reached plateau after refilling (Fig. 35 B) of 54 ± 5 µM (mean ± s.e.m., n 
= 13) and an initial Ca2+ uptake rate (Fig. 35 C) of 0.85 ± 0.07 µmol Ca2+/s 
(mean ± s.e.m., n = 13).
The over-expression of PS2-T122R or PS2 wt, does not  alter, within the trans-
Golgi, neither the plateau reached after refilling, (Fig. 35 E) neither the initial 
uptake rate (Fig. 35 F).
These results thus suggest that the over-expression of the FAD-linked PS2-
T122R (and similarly  of wt PS2) decreases ER and medial-Golgi [Ca2+] by 
inhibiting SERCA activity, whereas it  doesn’t affect SPCA1 activity  and, 
consequently, trans-Golgi [Ca2+].
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Fig. 35: Representative FRET  variations of mGo-D1cpv (A) and tGo-D1cpv (D) in PS2-T122R 
 or PS2wt expressing SH-SY5Y cells, in response to different stimuli. Averaged FRET 
 and [Ca2+] values of medial-GA (B) or trans-GA (E) plateau reached after refilling and 
 (C and F) averaged [Ca2+]/s values for the first 10 s of Ca2+ uptake in control,  
 PS2-T122R and PS2wt expressing SH-SY5Y cells  (mean ± s.e.m.; n ≥ 13).
A B
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Similar results for the ER and the medial-GA have been obtain in fibroblasts 
from the FAD_PS2-N141I patient compared to controls (Fig. 36).
PS2-N141I human fibroblasts transiently expressing ER-D4 or mGo-D1cpv, 
have shown both a significantly reduced plateau reached upon Ca2+ refilling and 
reduced Ca2+ uptake rate (Fig. 36 A and D). Indeed, for the ER, the plateau 
values (Fig. 36 B) were of 805 ± 50 µM, 760 ± 40 µM, 755 ± 50 µM  (mean ± 
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s.e.m., n ≥ 10) in the three controls (PS2 ctrl 1-3) and 507 ± 40 µM  (mean ± 
s.e.m., n = 9) in PS2-N141I fibroblasts. Within the medial-GA, the plateau 
reached after refilling (Fig. 36 E) was of 42 ± 3 µM, 45 ± 6 µM, 45 ± 4 µM 
(mean ± s.e.m., n ≥ 6) in the three controls (PS2 ctrl 1-3) and 14 ± 2 µM (mean ± 
s.e.m., n = 4) in PS2-N141I fibroblasts. As in SH-SY5Y cells, the ER initial Ca2+ 
uptake rate (Fig. 36 C) in PS2 control fibroblasts (ctrl 1-3) was, respectively, of 
6.9 ± 0.33 µmol Ca2+/s (mean ± s.e.m., n = 10), 6.56 ± 0.47 µmol Ca2+/s (mean ± 
s.e.m., n = 11), 6.71 ± 0.42 µmol Ca2+/s (mean ± s.e.m., n = 10) and of 3.9 ± 0.46 
µmol Ca2+/s (mean ± s.e.m., n = 9) in PS2-N141I fibroblasts. Within the medial-
GA (Fig. 36 E) the same parameter was of 0.99 ± 0.14 µmol Ca2+/s, 0.92 ± 0.16 
µM Ca2+/s, 0.96 ± 0,1 µmol Ca2+/s (mean ± s.e.m., n ≥ 6), in the three controls 
(PS2 ctrl 1-3) and 0,41 ± 0,07 µmol Ca2+/s (mean ± s.e.m., n = 4) in PS2-N141I 
fibroblasts.
Pag. 66
AC
D
B
E
F
Fig. 36: Representative FRET variations of ER-D4 (A) and mGo-D1cpv (D) in PS2-N141I 
 fibroblasts and corresponding controls, in response to different stimuli. Averaged 
 FRET and [Ca2+] values of ER (B) or medial-GA (E) plateau reached after Ca2+ 
 refilling and (C and F) avereged [Ca2+]/s values for the first 10s of the Ca2+ uptake in 
 controls and PS2-N141I fibroblasts (mean ± s.e.m.; n ≥ 4).
3.4 FAD-linked PS2 increases medial-Golgi, but not ER Ca2+ leak
In addition to the Ca2+ uptake, also the Ca2+ leak of an organelle could 
determined its steady-state [Ca2+].
In order to study if organelles leak of Ca2+ were also affected by  the over-
expression of FAD-linked PS2 mutants, control SH-SY5Y cells were pre-treated 
in extracellular medium containing EGTA (300 µM), at 4 C° for 20 minutes 
before starting Ca2+ measurement, to match the Ca2+ content within the ER or the 
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medial-GA of over-expressing PS2 (wt and T122R) cells (Fig. 37 A, B, D and E). 
Upon this protocol, control cells showed an initial ER [Ca2+] of about of 264 ± 
15 µM (mean ± s.e.m., n = 9), very similar to the Ca2+ ER levels found in PS2 
(wt and T122R)-expressing cells (264 ± 9 µM (mean ± s.e.m., n = 9) and 275 ± 
11 µM (mean ± s.e.m., n = 7), respectively; Fig. 37 B).
In the same way, control cells showed an initial medial-Go [Ca2+] of about 45 ± 4 
µM  (mean ± s.e.m., n = 9), similar to those of PS2 (wt and T122R) expressing 
cells  (47 ± 5 µM  (mean ± s.e.m., n = 10) and 44 ± 4 µM (mean ± s.e.m., n = 10), 
respectively; Fig. 37 E).
The over-expression of PS2 wt increased spontaneous Ca2+ leak from the medial-
Golgi after perfusing an extracellular medium containing CPA and EGTA, to 
visualize it  (Fig. 37 D and F). A similar, but  weaker effect was observed upon the 
over-expression of PS2-T122R. Indeed, the initial leak rate (calculated as the 
minimal values of the first derivate of the momentaneous [Ca2+]) were -0.2 ± 
0.03 µmol Ca2+/s (mean ± s.e.m., n = 9), -0.4 ± 0.07 µmol Ca2+/s (mean ± s.e.m., 
n = 10) and -0.7 ± 0.08 µmol Ca2+/s (mean ± s.e.m., n = 11) for control, PS2-
T122R and PS2 wt over-expressing cells, respectively (Fig. 37 F).
Contrariwise, similar experiments in SH-SY5Y cells with the ER probe 
demonstrated that the over-expression of both PS2 wt and mutated does not 
affect ER Ca2+ leak (Fig. 37 A and C): the calculated initial leak rate was -2.65 ± 
0.18 µmol Ca2+/s (mean ± s.e.m., n = 9), -2.95± 0.23 µmol Ca2+/s (mean ± s.e.m., 
n = 7) and -2.99 ± 0.36 µmol Ca2+/s (mean ± s.e.m., n = 8) for control, PS2-
T122R and PS2 wt over-expressing cells, respectively(Fig. 37 C).
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Fig. 37: Representative FRET variations of ER (A) and mGo-D1cpv (D) in PS2-T122R or PS2 
 wt expressing SH-SY5Y cells, in response to different stimuli. Averaged FRET and 
 [Ca2+] values of ER (B) or medial-GA (E) at initial [Ca2+] level and (C and F) averaged 
 [Ca2+]/s values for the first 10s of Ca2+ leak in PS2-T122R, PS2wt expressing or 
 control SH-SY5Y cells  (mean ± s.e.m.; n ≥ 13).
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Discussion and conclusions
Direct information on the Ca2+ homeostatic mechanisms in the GA of living cells 
has been obtained for the first  time in the 90's, using an aequorin chimeric 
construct localized to this organelle lumen (Pinton P. et al., 1998). In this paper 
it has been demonstrated that the GA (as a whole) behaves, in terms of Ca2+ 
handling, similarly to the ER.
More recently, in our lab, using a novel GFP-based Ca2+ probe selectively 
localized to the trans-Golgi, tGo-D1cpv, it has been demonstrated that this GA 
sub-compartment is endowed with unique characteristics that differ completely 
from those of the ER. In particular, it  has been shown that the trans-Golgi is IP3-
insensitive and utilizes solely  SPCA1 for its Ca2+ uptake (Lissandron V. et  al., 
2010).
During my PhD, another cameleon Ca2+ probe able to measure the [Ca2+] in the 
medial-GA has been generated in the lab; this probe has revealed additional 
complexity and heterogeneity in the Ca2+ handling of the entire organelle. 
Indeed, the characteristics, and the molecular components involved, of the Ca2+ 
handling in this latter GA sub-compartment are totally  different from those of the 
trans-GA. The medial-GA appears to accumulate Ca2+ within its lumen taking 
advantage of both SERCA and SPCA1 and it is an IP3- and Ry-sensitive Ca2+ 
store. Thus, within the GA in a space of a few microns, and despite its 
continuous inter-mixing dynamics, there are separate functional entities with 
clearly distinct Ca2+ handling mechanisms.
In the second part of my PhD, we generated a cameleon Ca2+ probe targeted to 
the ER, with appropriate features to measure its [Ca2+], named ER-D4.
Using the two new probes and that targeted to the trans-Golgi, the specific effect 
on intracellular Ca2+ stores of the expression of FAD-linked PS mutants was 
evaluated. Indeed, impairment of cellular Ca2+ signalling has been causally 
associated to ageing and several neuronal disorders, including AD (Mattson M.P. 
et al., 2000). In particular, previous data from our lab have demonstrated that 
FAD-PS2 mutations reduce ER and GA Ca2+ levels, in particular by inhibiting 
SERCA activity (Zatti et al., 2006 and Brunello et al., 2009).
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My results further indicate that the expression of FAD-linked PS2 mutants (but 
not PS1) cause dysregulations in ER and medial-Golgi Ca2+ handling. In 
particular, they strengthen the idea that FAD-PS2 mutants act on intracellular 
Ca2+ content by affecting SERCA-2 activity, thus reducing stored Ca2+ and thus 
its release in the cytosol upon different cell stimulations. 
The result  of a decreased intracellular store Ca2+ content in the presence of FAD-
PS2 mutants is however a debated issue. On one hand, Foskett’ s group proposed 
that PSs, both PS1 and PS2, can regulate the sensitivity of the IP3R, with their 
FAD mutants increasing its open probability  at low IP3 concentrations; this 
molecular effect results in an exaggerated Ca2+ signals in response to agonist 
stimulation, as well as in a higher degree of constitutive Ca2+ signalling, without 
however affecting intracellular store Ca2+ content (Cheung K.H. et al., 2010). On 
the contrary, data from another group sustained the “Ca2+ overload” hypothesis, 
in which an increased Ca2+ content in intracellular stores in the presence of FAD-
PSs mutants is observed. According to this hyphothesis, wt PS holoprotein forms 
ER Ca2+ channels that comprise a passive ER Ca2+ leak, while FAD-PSs mutants 
have lost this functionality and thus cause an ER Ca2+ overload (Nelson O. et al., 
2010). 
Recently, a new study has shown that PS2, but not PS1, emerges from a broad 
screening as a protein able to cause an ER Ca2+ leak (Bandara S. et al., 2013), 
and thus a reduction in ER Ca2+ content, sustaining our data. Moreover, the fact 
that in our experiments PS2 wt behaves as the FAD mutant forms only when it  is 
largely  over-expressed, suggest that FAD-PS2 effect on Ca2+ homeostasis is due 
to a toxic “gain of function”, as demonstrated for other PS features (Haas C. et 
al., 1999).
The main question is whether and how this alteration may contribute to the 
pathogenesis of FAD. A reduced ER Ca2+ release is expected to influence 
negatively ER-mitochondria Ca2+ transfer, with a reduction in mitochondrial 
functions but also an increased resistance to apoptotic stimuli. Indeed, as 
demonstrated in several models of cell death, a reduction in the ER Ca2+ content 
is partially protective against a variety  of cytotoxic insults (Pinton P. et al., 
2001). In our lab, however, it has been previously demonstrated that endogenous 
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PS2 and, more potently FAD-PS2 mutants (but not FAD-PS1 mutants), have an 
additional effect, increasing the physical tethering between ER and mitochondria 
and their Ca2+ cross-talk (Zampese E. et al. 2011). This latter feature further 
complicates the possible PS2 mechanism of action, since the stronger ER-
mitochondrial tethering could compensate the reduced ER Ca2+ content, locally 
inducing a mitochondrial Ca2+ overload that, in concomitance with other toxic 
stimuli, i.e., Aβ peptide, could be detrimental for cell life. Indeed, it has been 
demonstrated that a chronic mitochondrial Ca2+ overload may activate the 
apoptotic pathway (Pizzo P. et al., 2012). 
Alternatively, the reduced store Ca2+ content induced by the expression of FAD-
PS2 mutants, but not of FAD-PS1 mutants, may in someway be protective against 
a variety of cytotoxic insults, avoiding mitochondria Ca2+ overload. The 
increased ER-mitochondria apposition caused by FAD-PS2, on the other hand, 
could be necessary to maintain the proper ER-mitochondria Ca2+ transfer needed 
for cell viability  even in the presence of a reduced ER Ca2+ content. This 
hypothesis could explain the late-onset and less aggressive AD phenotype linked 
to PS2 mutations, compared to that linked to PS1 mutations, being these latter 
unable to modify ER Ca2+ content.
Whether the abnormalities in Ca2+ homeostasis caused by FAD-PS2 mutants 
expression, both as reduced Ca2+ store content and favoured mitochondria Ca2+ 
uptake, could have a key  role in cell viability, toxicity and eventually  cell death 
will be the topic of further investigations.
We here show evidence that the PS2-T122R mutation causes a reduction in ER 
and medial-Golgi Ca2+ content.
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Abbreviations
[Ca2+]: Calcium concentration
AA: Amino acids
Aβ: Amyloid-β
AD: Alzheimer’s disease
ADAM: α disintegrin and metalloproteinase
AICD: APP intracellular domain
APH1: Anterior pharynx-defective1
APP: Amyloid precursor protein
BACE1: β-site APP cleaving enzyme 1
BK: Bradykinin
Ca2+: Calcium
Caff: Caffeine
CaM: Calmodulin
CARP: carbonic anhydrase-related protein
cDNA: complementary DNA
CFP: Cyan fluorescent proteins
CGN: Cis Golgi network
CICR: Ca2+-induced Ca2+ release
CNS: Central nervous sisystem
CNX: Calnexin 
CPA: Cyclopiazonic acid 
CRAC: Ca2+ release-activated Ca2+ channel
CRT: Calreticulin
CSQ: Calsequestrin
Dig: Digitonin
E-C: Exitation - contraction 
ER: Endoplasmic reticulum
FAD: Familial Alzheimer’s disease
FP: Fluorescent protein
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FRET: Fluorescence resonance energy transfer
GA: Golgi apparatus
GECIs: Genetically encoded Ca2+ sensors
GRP78: Glucose-related protein78
GRP94: Glucose-related protein94 
IP3R: IP3 receptor
Iono: Ionomycin
Kd: Dissociation constant
LOAD: “late-onset” AD
M13: CaM binding peptide of myosin light chain kinase M13
MBDs: Microtubule-binding domains
MCU: Mitochondrial Ca2+ uniporter
mGoD1cpv: Medial Golgi-D1cpv
mKRB: Modified Krebs-Ringer buffer
NAADP: Nicotinic acid adenine dinucleotide phosphate
NFT:  Neurofibrillary tangle
PEN2: Presenilin enhancer 2
PIP2: Phosphatidyl inositol bis-phosphate
PLC: Phospholipase C
PP1: Protein phosphatase 1
PP2A: Protein phosphatase 2A
PS: Presenilin
PS1: Presenilin-1
PS2: Presenilin-2
Ry: Ryanodine
RyRs: Ryanodine receptors
sAPP-α: Secreted Extracellular Domain
SERCA: Sarco/endoplasmic reticulum calcium ATPase
SOCCs: Store-operated Ca2+ channels
SPCA1: Secretory pathway Ca2+ ATPase1
SR: Sarcoplasmic reticulum
STIM1: stromal interacting molecule
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t-BHQ: 2,5-di-(ter-butyl)-1,4-benzohydroquinone
Tg: Thapsigargin
TGN: Trans Golgi network
TPC: Two pore channel
VOCCs: Voltage-operated Ca2+ channels
wt: Wild type
YC: Yellow cameleon
YFP: Yellow fluorescent proteins
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